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ABSTRACT 
The investigation has been concerned with the application of the Baylis-Hillman methodology to 
the synthesis of quinoline derivatives. An extensive range of novel Baylis-Hillman products has 
been prepared, typically in moderate to excellent yields, by condensing 2-nitrobenzaldehyde 
derivatives with various vinyl ketones and acrylic esters in the presence of 
diazabicyclo[2.2.2Joctane (DABCO). Reduction of the nitro group in the Baylis-Hillman products 
was effected by catalytic hydrogenation in ethanol using a 10% palladium-on-carbon catalyst to 
afford quinoline, quinoline-N-oxide and quinolone derivatives. In all cases, it is apparent that 
cyclisation involves exclusive attack of nucleophilic nitrogen at the carbonyl centre, with acrylic 
ester derivatives affording quinolones and vinyl ketone derivatives affording quinolines and the 
corresponding quinoline-N-oxides. No products arising from a conjugate addition pathway were 
observed. The use of stannous chloride as an alternative reagent to effect reductive cyclisation of 
the Baylis-Hillman products has been explored, and found to favour the formation of 1,2-
dihydroquinoline derivatives, with cyclisation occurring via a conjugate addition pathway. Isolation 
of the products, following work-up of the stannous chloride reactions, however, presented some 
difficulty. All compounds were characterised by spectroscopic (NMR and IR) and, where 
appropriate, elemental (high-resolution MS) analysis. 
Interconversion of the quinoline and quinoline-N-oxide derivatives has been explored and finally 
achieved in quantitative yields. Reduction of 2,3-dimethylquinoline-N-oxide to the corresponding 
quinoline was effected using phosphorus tribromide in DMF, and the reverse transformation with 
meta-chloroperbenzoic acid (MCPBA) in CHCll. Application of these methods to mixtures of2,3-
dimethylquinoline and its N-oxide has afforded, selectively, either the quinoline derivative or the 
corresponding N-oxide. 
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Introduction 
1. INTRODUCTION 
1.1 STRUCTURE AND ISOLATION OF QUINOLINE 
Quinoline (l-azanaphthalene or benzo[b ]pyridine) 1 is one of the three possible azanaphthalenes, 
the other two being isoquinoline 2 and the quinolizium cation 3. The bicyclic ring structure, first 
. suggested by Komer, 1 was established on the basis of the constitution, syntheses and chemical 
properties of quinoline itself; the Friedlander synthesis and degradative oxidation and ring-
opening reactions were particularly important in supporting this suggestion. The structure has 
also been confirmed by X-ray crystallographic analysis of derivatives and by various spectroscopic 
techniques. 1 
5 4 
6~3 
7~?2 
8 1 
5 4 600"'" 3 
7 ~ I .,-; N2 
8 1 
9 1 
8~2 7~~V3 
6 4 
1 2 3 
A large number of heterocyclic compounds have been found in nature, and their isolation and 
study have led to great advances in the field of heterocyclic chemistry. Quinolines form an 
important group of compounds in this field, ' with many of the naturally occurring quinolines 
exhibiting significant biological activity. In 1834, Runge isolated crude quinoline from tar, the 
sample presumably also containing isoquinoline and alkyl derivatives of both bases. 1.3 Eight years 
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later, 
Gerhardt ' isolated quinoline from the alkaloids cinchonine 4 and quinine 5 by vigorous distillation 
in the presence of alkali. In fact, the name, quinoline, is derived from the word, quinine, which, 
in tum, is derived from quina, a Spanish version of a local South American name for the bark of 
quinine-containing Cinchona species' Quinoline has also been obtained from tobacco by 
destructive distillation, from crude petroleum and shale oil and by direct synthesis. 
R 
N 
4: R=H; cinchona 
5: R=OMe; quinine 
1.2 SYNTHESIS OF QUINOLINE DERIVATIVES 
Numerous reactions have been used to prepare quinolines, and various approaches are possible. 
These differ according to which ofthe bonds (a) - (d) (Figure 1) completes the ring-closure and 
the method of introducing the missing carbons. The synthon types 7 - 10 represent the most 
common strategies. The first syntheses of quinolines were reported by Koenigs. ' In one method, 
the vapours of ethylaniline, or other alkylanilines , were passed over heated litharge, while in a 
2 
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second, the addition product of aniline and acrolein was heated. These syntheses were followed 
by those ofSkraup, ,5 and of Doebner and von Miller.' 
(()
d C 
7' "" I b 
::::,.... /5 
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6 
(XI C? ::::,.... N C 
7 8 9 10 
Figure l. Common diconnections for the construction of quinolines 
1.2.1. The Skraup Synthesis 
The most widely used method for synthesising quinoline is the one developed by Skraup; ',5 it can 
also be applied to the preparation of many quinoline derivatives, In this synthesis, a quinoline is 
produced when an aniline derivative with a vacant ortho-position is heated together with 
concentrated sulphuric acid, glycerol and a mild oxidizing agent. The initial stages ofthe reaction 
may be very vigorous and can be moderated by the inclusion of ferrous sulphate.' The reaction 
has been shown to proceed via acid-catalysed elimination of water from glycerol II to form 
3 
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acrolein 12 (Scheme 1); conjugate addition of the aniline 13 to acrolein follows, resulting in the 
formation of an anilinopropanal intermediate 14. Ring-closure then results from electrophilic 
attack by the carbonyl carbon at the ring position ortho to the amino group; subsequent 
dehydration gives the dihydroquinoline 17, oxidation of which affords the quinoline product 18. 
CH2(OH)CH(OH)CH20H 
11 
Scheme 1 
• 
• 
CH2 =CH-CHO 
12 
16 
CO"""""" ~ N 
R H 
17 
loxidation 
CO R N 
18 
With glycerol 11 as the precursor for the key intermediate, acrolein 12, the quinoline will contain 
no substituents in the heterocyclic ring but, if a substituted quinoline is required , glycerol may 
be replaced with pre-formed a,~-unsaturated carbonyl compounds 20 having the appropriate 
4 
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substituents (Scheme 2).' Thus, crotonaldehyde 20a gives 2-methylquinoline 21a, and methyl 
vinyl ketone 20b gives 4-methylquinoline 21b. 
R3 
RJ R2 I U NH2 O-~ '-'::: + CR2 • II /-CHRI N RI 
19 20 
21 
a: Rl=Me; R2=R3=H 
b: Rl =R2=H; R3=Me 
Scheme 2 
Many attempts have been made to prepare quinoline directly from acrolein, but good yields were 
obtained only when acrolein vapour was passed into a mixture of aniline, sulphuric acid and an 
oxidizing agent. It appears that, under ordinary conditions, the acrolein is polymerized before 
it can combine with the aniline. Substituted anilines can be used to give quinoline derivatives 
with substituents in the carbocyclic ring.' Of course, anilines substituted at the ortho position have 
only one site for ring-closure and thus give 8-substituted quinolines. Symmetrical para-
substituted anilines undergo ring-closure at either of the ortho positions to give 6-substituted 
quinolines, but meta-substituted anilines can give both 5- and 7-substituted quinolines. The 
Skraup synthesis cannot, however, be used on compounds which contain acid-labile substituents. 
Apart from this limitation, the Skraup synthesis is considered to be the best available method for 
the synthesis of quinolines unsubstituted on the heterocyclic ring4 
5 
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1.2.2. The Combes Synthesis 
In this method, a 1,3-dicarbonyl compound is condensed with an aryl amine to give a p-imino 
ketone, which can then be cyclized by treatment with concentrated acid' The cyclization step 
involves electrophilic substitution by the O-protonated imino ketone followed by dehydration to 
give the quinoline. Thus, reaction of heptane-3 ,5-dione 22 with aniline 19 gives 2,4-
diethylquinoline 24 (Scheme 3). When 2-substituted malonic esters 25 are reacted with an 
aromatic amine in diphenyl ether under nitrogen, 3-substituted 4-hydroxy-2-quinolones 27 are 
fonned, the initial linking reaction, in this case, involving nucleophilic acyl substitution rather 
than nucleophilic addition at the carbonyl centre. 
0 Et 
:~a II Et Q NH heat ONC~ H:zS°4 ~ + ~ • -< 2 N Et 
Et 
19 22 23 24 
0 OH 
OEt II -",~Et 
O=< QC 
~ R 
Q+ 
c::7 'CHR 
CHR • ~ I N~O ~ ~ NH o=( N 0 2 H OEt H 
19 25 26 27 
Scheme 3 
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1.2.3. The Conrad-Limpach and Knorr syntheses 
Other reactions commonly used to prepare quinolines are the closely related Conrad-Limpach and 
Knorr syntheses. In these reactions, an aromatic amine is reacted with a p-keto-ester, such as 
ethyl acetoacetate, to give 2- or 4-quinolones, which can be readily converted to chI oro qui no lines 
with phosphoryl chloride and then reduced to quinolines. I.3·4 The p-keto-ester 28 contains two 
different types of carbonyl group and, at low temperature (20°C), the amino group condenses with 
the more reactive keto carbonyl (kinetic control) to give a p-aminoacrylic ester 29 which, on 
heating, cyclizes to give the 4-quinolone 30 (Scheme 4). At higher temperatures (110-140 0c). 
the more stable amide 31 is formed (thermodynamic control) after interaction of the aryl amine 
with the ester group; the resulting anilide undergoes ring-closure on heating, alone or with 
OEt 
0 
or I 20 0 C 250 0 C ~ Conrad- ~ 
Limpach synthesis :::::.... N N H H 
U NH: 29 30 CH3COCH2C02Et 
19 28 
110 - 140 oC or H2SO4 ~ ~ .. .. heat Knorr synthesis :::::.... N ~O :::::.... N ""0 
H H 
31 32 
Scheme 4 
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sulphuric acid, to give the 2-guinolone 32. The kinetically controlled process is known as the 
Conrad-Limpach synthesis, the thermodynamically controlled reaction as the Knorr synthesis' 
1.2.4. The Friedlander synthesis 
In the Friedlander synthesis, substituted guinolines 36 are formed by the condensation of 0-
aminobenzaldehydes or o-aminoacetophenones 33 with aldehydes, ketones and other compounds 
which contain an a-methylene group.' In this reaction (Scheme 5), the first stage involves the 
base-catalysed formation of a Schiff base 35; this is followed by ring-closure between carbons 3 
and 4 of the guinoline ring by a Knoevenagel condensation. 
0 
R4 
RI 
NH2 0 
R4 
d R3 33 NaOH or c:7 R4 ~ RI I ~R3 • RI + piperid ine ~ R2 '" N R2 ):: 35 36 
34 
Scheme 5 
The disadvantage of this method is that aminobenzaldehydes are bifunctional and prone to self 
8 
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condensation. This problem may be controlled either by use of the Pfitzinger modification (see 
section 1.2.5) or by use of the less reactive nitro compounds in place of the amines.' Under the 
latter conditions, the Knoevenagel condensation occurs first, and ring-closure to the nitrogen can 
be achieved by reduction of the nitro group. This is illustrated by the formation of 2-
aminoquinoline 41 from o-nitrobenzaldehyde 37 and acetonitrile 38 (Scheme 6) 
CCCHO OC (J() I : N~ NaOEI I I Sn """ I CN .. .. """ CN HC! N~ NH2 
37 39 40 1 NaOH + 
CH3CN 
38 ~ I 
""" h N NH2 
Scheme 6 41 
1.2.5. The Pfitzinger Synthesis 
The ortho-aminobenzaldehydes required for the Friedlander synthesis are often not easy to obtain, 
and this modification makes use of substituted isatinic acid (o-aminobenzoylformic acid) 
deri vatives 45 (Scheme 7), which are formed by alkaline cleavage of the isatin lactam ring. 
Condensation with a keto-methylene moiety, or its oxime, gives a quinoline-4-carboxylic acid, 
9 
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such as compound 46. I Many such compounds have been prepared for transformation into 
derivatives for pharmacological testing as antimalarials' If the 4-carboxyl group is not required, 
it can readily be eliminated by pyrolysis with calcium oxide or copper powder. 
42 43 
C02H Me 
Me OPh 
'-":::: MeCOCH2OPh 
.. 
h 
N Me 45 
46 
Scheme 7 
1.2.6. The Doebner-von Miller synthesis 
44 
laq KOH, r.t 
~O 
The Doebner-von Miller synthesis is closely related to that of Skraup, and involves heating a 
primary aromatic amine with an aldehyde in the presence of an acid; however, no oxidizing agent 
is used. The pioneers of this reaction used ethylene glycol ( from which acetaldehyde can be 
10 
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Pht€) 
Ph to PhNH 47.~ H Obl H+ -;/ H+ • • Q "'" "'-+ N Me N Me H H 
"'" N$'Me 49 50 
I 
l-H+ 48 H 
Ph H 
~ - PhNH2 c::? ~ [0] "'" IN"'" M e .. I .. """-# N Me N Me H 
H 
53 52 51 
Scheme 8 
formed by the elimination of water), but other aldehyde precursors, such as paraldehyde or acetals, 
may be used in place of the aldehyde itself.' The condensing agent typically used is zinc chloride, 
and it has been proposed that the quinoline system 53 is formed as a result of the self-condesation 
of two molecules of the Schiff base, obtained by condensation of the aromatic amine and the 
aldehyde (Scheme 8); the nucleophilic species is depicted as the tautomer 47 and the electrophile 
as the ketimine 48. 
1.2.7. Cyclisation of o-amino derivatives of cinnamic acid 
Ortho-amino alla-cinnamic acid derivatives readily undergo ring closure to give 2-quinolones. 
The a-amino trans-cinnamic acid derivatives (obtained by reduction of the corresponding nitro 
11 
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compounds), on treatment with acetic anhydride or sulphuric acid, give bimolecular 
anhydrides, which rearrange to the cis-isomer on heating; subsequent cyclisation gives the 2-
quinolones 56 (Scheme 9) . Claret' cites this reaction as one of the earliest syntheses of the 
quinoline ring system. 
~o 
56 
Scheme 9 
1.2.8. CycIisation of cinnamanilides 
When heated with polyphosphoric acid, cinnarnanilides 57 afford 4-aryl-3,4-dihydro-2-quinolones 
58 (Scheme 10). The reaction is successful with a variety ofpara-substituents (R') in the 4-aryl 
ring, but ortho-substituents hinder ring-closure. Electron-withdrawing groups in the 
benzannulated ring may also prevent ring closure, while strongly electron-releasing groups may 
cause loss of the aryl group if the reaction temperature is not kept as low as possible.' When 
aluminium chloride is used as a catalyst, 2-quinolones 59 are, in fact, formed with elimination 
ofthe aryl group. 
12 
RI 
~ 
R2-Q~ ~ N 0 
H 
57 
Phosphoric acid, 
100 - 190 oC, 
10 - 30 min 
AlCl] (3 eq ) 
100 DC, I h 
R2 
.. 
Scheme 10 
1.2.9. Ring-enlargement methods 
Introduction 
RI 
0 
58 
RID """ R2 + 
N 0 
H 
59 60 
The quinoline derivatives 62 - 64 can be prepared from the indole 61 by ring-enlargement using 
alkyl halides (routes I and II) or dichlorocarbene (route III) (Scheme 11).1 The hydroxyquinolone 
66 (Scheme 12) can be obtained by treating isatin 65 with diazomethane, while the oxime of 
indan-l-one 67 undergoes a Beckmann rearrangement to give 3,4-dihydro-2-quinolone 68 
(Scheme 13). 
13 
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I ()()Me Mel,100 oC I 62 
"'" ~ // N 
Me 
(r}-Me 
II OCCMe 2 EtI I 63 "'" N "'" N// Me H 
61 Et 
III OCCO CHCIJ+NaOEt I 64 (:CCl2) 
"'" N// Me 
Scheme 11 
0 
-::7 ~ OH 
-::7 CH2N2 
0 ~ 
"'" 
~ 
N N 0 
H H 
65 66 
Scheme 12 
~ 
PCls 
• ~ 0 
67 0 68 
Scheme 13 
14 
Introduction 
1.2.10. Miscellaneous Syntheses 
Perumal el al.' have reported the synthesis of various 6-substituted 4-chloro-3-methylquinolines 
71 from 1-(2-aminophenyl)propanones using a Vilsmeier reagent (Scheme 14). They also 
extended the scope of the reaction by introducing an acetyl group on to the nitrogen atom of the 
substrate to obtain similar products, and observed a remarkable improvement in the yield of the 
product - a result attributed to the susceptibility of the free amino group to undergo N-formylation, 
thus interfering with the cyclization step. 
0 
R 
""" 
DMF, POCI) 
# 90 oC, 4-6 h CI NH2 
69 ( R~H, CI, Br) R 
""" """ 
# h 0 N 
R 71 
""" 
# DMF,POCI3 NH 90 oC, 4-6 h A ( R~H, Br, N02 ) 
0 
70 
Scheme 14 
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The reaction of N-methylformanilides 72 with N-alkylmorpholides 74 in the presence of excess 
phosphorous oxychloride has been shown to give 4-chloro-N-alkylquinolinium salts 76 and, 
hence, l-alkyl-4-quinolones 77 (Scheme 15)7 .• The N-alkylmorpholide is converted, in situ, to 
a chloroenamine 75, which then adds to an iminium salt 73, generated from the N-
alkylformanilide. This methodology has been adapted to provide a short and efficient route to 
norfloxacin 78 and related antibiotics.',',' 
QN~O Q POCl3 I + • ~ ~CI CI 
I I 
Me Me R 
72 
'OPOCl2 ""'" ""'" 
73 # + """ N OPOCl2 I 
01 o - 76 Me ~NnR POCl] • 
NY"R t20 74 0 CI 
75 0 
""'" 
R 
0 
# N F 
""'" 
C02H I 
77 Me 
r
N # N 
I HN~ Ei 
78 
Scheme 15 
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Organometallic methodology has been applied in a synthesis of the 2-chloroquinoline derivative 
84 (Scheme 16), for which 1.2,4-trimethoxy-3,5-dinitrobenzene 79 was used as starting material.9 
Catalytic hydrogenation of the dinitro compound 79 afforded, quantitatively, 3,5-diamino- l ,2 ,4-
trimethoxybenzene, which was transformed into the dipivaloylamino derivative 80 by treatment 
with pivaloyl chloride. Metallation of the diamide 80 with butyllithium at 0 DC, followed by 
reaction with iodine, afforded the iodo derivative 81. A Heck reaction with methyl acrylate, in the 
presence of a catalytic quantity (3%) of palladium diacetate at 100°C in a sealed tube, gave the 
trans-cinnamate ester 82, the somewhat drastic conditions being necessary due to steric hindrance 
at the nucleophilic centre. Cyclisation of the ortho-aminocinnamate derivative 82 was carried out 
in acidic medium and, finally , chlorination of the quinolone 83 with POC1) afforded the 2-
chloroquinoline 84. I 0 
Two unusual methods of synthesising quinolines are illustrated in Scheme 17. In the first, 
cinnoline 85 reacts with ynamides 86 in boiling dioxan with elimination of hydrogen cyanide, to 
give the diethylamino derivative 87. 7•11 In the second, access to 2,4-disubstituted quinolines of 
types 91 and 92 has been achieved starting from 2-aminothiopheno188 and acetylenic acetals 89 
to yield various substi tuted benzol b )[1 ,4)thiazepine intermediates of type 90. Subsequent sulfur 
extrusion in refluxing toluene led to the 2,4-disubstituted quinoline acetals 91, which may be 
hydrolysed to the corresponding 2-substituted quinoline-4-carbaldehydes 92. The unstable 
benzothiazepines 90 can be isolated, but extrude sulphur when heated7 .1 2. ' 3 
17 
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OCH) OCH) i) BuLi, TMEDA, 
CH)O i)H2, Pd-C CH)O 9" THF OOC 9" ii) ButCOCI • ii) 12, THF, 0 °c 
~ NEt), THF PivNH ~ NHPiv 02N N02 
OCH) OCH) 
79 80 
OCH) OCH) 
CH)O ~C02CH3 CH)O 9" 9" C02CH3 « 
Pd(OAc)2, 
PivNH ~ NHPiv 
PivNH ~ NHPiv 100
0 C 
OCH3 82 
OCH3 
81 
1 HCI, 
heat, 48h 
OCH3 OCH) 
CH30 CH)O ~ ~ POCl3 
.. 
H2N # N 0 H2N CI 
H OCH3 OCH3 
83 84 
Scheme 16 
Quinoline derivatives, both naturally occuring and synthetic, have been reported to exhibit a wide 
spectrum of biological activities, including bactericidal, antitumour, antimalarial 14-19 and anti-
inflammatory.',2o-22 The following sections will focus on quinolines as antimalarials (1.3), 
antibacterials (1.4) and HIV -1 integrase inhibitors (1.5) _ 
18 
85 
o (XSH I + ~ NH] R 
88 89 
86 
OEt 
OEt 
CHO 
92 
[-HCN] 
• • dlOxan, 
heat 
i)THF, -78oC 
• 
ii)PPTS, 0 0C 
HC02H, 50 0C 
• 
R 
Scheme 17 
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87 
EtO 
OEt as 
N 
R 
90 
1 Toluene, heat 
EtO OEt 
~ 
"'" 
~ h' N R 
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1.3 QUINOLINE ANTIMALARIALS 
1.3.1 Cinchona Alkaloids 
Despite major campaigns to eliminate malaria, the disease is still one of the most significant health 
problems in many parts of the world 21 The earliest of the antimalarials was quinine, an alkaloid 
which was first extracted from the bark of the cinchona tree in 1600 and which is still in use 4 
South American Indians, as mentioned earlier (Section 1.1), recognized the fever-reducing 
properties of cinchona bark, and crude cinchona extracts were introduced into Europe in the 
seventeenth century. The four major cinchona alkaloids (quinine, quinidine, cinchonine and 
cinchonidine; Figure 2) are all quinolinemethanol derivatives which bear a substituted 
quinuclidine ring system." Quinine is the most abundant alkaloid present in extracts of cinchona 
bark - to the extent of about 5 %. Although all four alkaloids show antimalarial activity, their C-9 
epimers are inactive." Any modification of the secondary alcohol function at C-9, through 
oxidation, esterification or other processes, diminishes activity and, while the quinuclidine 
portion is not necessary for activity, the 
H Z 
HO 9 8 R 
R OMe quinine (8S, 9R) 
,:7 ~ OMe quinidine (8R, 9S) 
H cinchonine (SR,9S) 
"""-
// 
N 
H ci nchonidine (8S, 9R) 
Figure 2 
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presence of a tertiary alkylamine attached to C-9 is important. These structural requirements 
formed the basis for the design of synthetic antimalarials ,24 and the quinolinemethanol moiety was 
targeted in the development of new drugs. 
The cinchona alkaloids act on the erythrocytic merozoites;24 they do not effect a radical cure from 
the disease but they do decrease symptoms. A major drawback to the use of these alkaloids is the 
wide spectrum of side-effects, including skin allergies , deafness, vertigo and slight mental 
depression. Despite these short-comings, the cinchona alkaloids are still used extensively in some 
parts of the world where the economics oflarge-scale drug delivery is problematic. Quinine is the 
drug of choice for chloroquine resistant Plasmodium Jalciparum, and it is interesting to note that 
resistance to quinine has not developed as readily as it has to the synthetic antimalarial agents." 
1.3.2 4-Aminoquinoline Derivatives 
The diminished supply of cinchona bark during World War II led to a search for synthetic 
antimalarial agents. Research efforts centred on modification of the quinine structure and , as a 
result, the 4-aminoquinoline antimalarials were developed, examples of which are illustrated in 
Figure 3 . These drugs are active against the erythrocytic forms of all malarial parasites and thus 
provide a clinical cure.24 However, they do not prevent the disease , and they are not active against 
the liver-infected forms 24 For all types of human malaria susceptible to treatment by 4-
aminoquinolines, chloroquine 93a or amodiaquine 93c have long been the drugs of choice for both 
chemotherapy and supressive chemoprophylaxis25 The 4-aminoquinolines, in general, and 
21 
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chloroquine, in particular, have been very effective in treating the erythrocytic forms of P. vivax 
and P. jaiciparum, being more potent erythrocytic schizontocides than quinine or the 9-
aminoacridines.24 A consideration of structure-activity relationships has revealed that the side-
chain length, the presence of a 7-chloro substituent and the introduction of a terminal hydroxyl 
group [as in hydroxychloroquine 93b) are critical for reducing toxicity and increasing plasma 
concentration of the drug. Incorporation of an aromatic ring in the side chain of chloroquine, as 
in amodiaquine 93c, produces a compound of reduced activity and toxicity. The toxicity of these 
compounds tends 
Rl 
R2 
CI 
~ ~ 
N 
93 a-d 
Rl R2 
~H5 
a NHCH(CH1)(CH2h-N~ H chloroquine 
~H5 
CH1 amodiaquine 
CH) sontoquine 
Figure 3. Selected 4-Aminoquinoline derivatives 
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to be low, but large doses may affect hearing and vision." Hydroxychloroquine 93b is, of course, 
but one of the large series of 4-aminoquinolines with antimalarial activity, and it has been used 
in malaria therapy since 1955 as an alternative to , or in combination with, chloroquine .26 
"Although hydroxychloroquine was developed primarily as an antimalarial agent, it possesses 
other pharmacological properties as well. 28 Its anti-inflammatory activity is well known, and it 
has been useful in the treatment of rheumatoid arthritis and in systemic lupus erythematosus". Its 
application in the treatment of photo-allergic reactions is also established. Tonnesen et al. 26 found 
that hydroxychloroquine also shows substantial binding to plasma proteins as well as to 
metabolically active tissues including the liver, spleen, lung and adrenal glands, where it 
accumulates, with long-term administration, reaching concentrations of 6000-8000 times the 
plasma level. It is also deposited in the epidermis in considerable amounts (at levels 100-200 
times the plasma concentration). Furthermore, hydroxychloroquine accumulates in melanin-rich 
areas of the body and is retained in the iris and choroid of the eye.26 Several side-effects are 
associated with the use of hydroxy chloroquine 93b; the drug has been reported to cause changes 
in skin-pigmentation and bleaching of the hair while, with long-term usage, it is likely to affect 
the cornea and retina of the eye2 S• 26 
1.3.3. Acridine Derivatives 
Ehrlich's early observation that methylene blue had some antimalarial activity led to the discovery 
of such activity in several acridine derivatives (94a-c; Figure 4)24 These agents act as 
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schizonticides but, as a class, are less effective than the 4-aminoquinolines. A side-effect oftheir 
use in therapy is yellow pigmentation of the skin and a yellow colouration of the urine. Acridine 
derivatives are, in fact, extremely toxic and have been largely replaced by the 4-aminoquinolines. 
RI 
CH30 ~ 
"""'" 
R2 
..;; 
.# N CI 
94 a-c 
Rl R2 
~H5 
a / 9-aminoacridine NHCH9CH]l(CH2h-N, H 
~H5 
~H5 
b / H acriquine NH(CH2l4-N, 
~H5 
~H5 / 
c NHCH9CH3)(CH2h-N, NH2 3-aminoacridine ~H5 
Figure 4. Some acridine derivatives 
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1.3.4. 8-Aminoquinoline Derivatives 
These synthetic compounds reflect a more pronounced departure from the quinine structure. The 
8-aminoquinoline, primaquine (95a; Figure 5), is the only drug now in general use that is 
effective against the persistent tissue stages of relapsing malarias and thus able to effect a radical 
cure25 Unlike the 4-aminoquinolines, the 8-aminoquinolines are active against pre- or 
exoerythrocytic activity, but do not show gametocidal activity. The presence of a 6-methoxy 
group and a 4- to 6-carbon chain appear to provide the best activity." The extent of substitution 
of the terminal amine moiety is not as critical as in the 4-aminoquinolines, and the drug of choice, 
primaquine, is a primary amine. 24 
~ 
N 
R 95 a-e 
R 
a NHCH(CH](CH2hNH2 primaquine 
/~H5 
b NHCH(CH])(CH2l]-N" pamaqume 
~H5 
/~H5 
C NH(CH2l]CH(CH]l-N" quinocide 
~H5 
Figure 5. Examples of 8-aminoquinoline derivatives 
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However, primaquine is far from being an ideal drug; the 8-aminoquinolines appear, in general , 
to be more toxic than the 4-aminoquinolines, producing side-effects which include gastric 
disturbance and leakopenia." The primary toxicity of primaquine is manifested as 
methemoglobinemia and as hemolytic anemia in persons with a genetic deficiency of the enzyme, 
glucose-6-phosphate dehydrogenase.24, 25 Unfortunately, this abnormality occurs, primarily, in 
areas of the world where malaria is endemic and, hence, the use of primaquine in such areas is 
not without risk. However, primaquine is still used in combination with chloroquine 93a to effect 
radical cures of P. vivax, and is the only drug currently available for the radical treatment of 
relapsing vivax or ovale malaria. 24,27 
1.3.5. Other Antimalarials 
Several bisquinolines, such as piperaquine, had been observed to possess notable activity against 
chloroquine-resistant malaria and, consequently, Vennerstrom and co-workers 28 prepared a series 
ofthirteenN,N-bis-(7-chloroquinolin-4-yl)alkanediamines (96a-l; Figure 6). Not only were these 
bisquinolines generally found to be active against chloroquine-resistant malaria but, relative to 
chloroquine, they also exhibited:- a significantly lower resistance index; greater potency; a longer 
duration of action; and reduced toxicity. Maximum activity was observed for bisquinolines with 
a connecting bridge (R) of only two carbon atoms, the decreased conformational mobility 
appearing to increase activity. 
Vennerstrom et al. 29 extended their study by preparing a further series of eleven N, N-bis(7-
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chloroquinolin-4-yl)heteroalkanediamine analogues (97 a-j) to examine the effects of incorporating 
oxygen or nitrogen atoms into the bisquinoline bridge on antimalarial activity and the inhibition 
of hematin polymerisation. On balance, the incorporation of nitrogen or oxygen atoms failed to 
improve antimalarial activity, the exceptions being the ether-bridged analogues (97 b-d) for which 
in vivo antimalarial efficacy was enhanced. Decreased in vivo antimalarial activity was especially 
evident for the bisquinolines (97 e-h), and it was suggested that the presence of the central bridging 
nitrogen probably allows rapid, metabolicN-dealkylation, which would convert these bisquinolines 
to mono qui no lines and, thus, offer no advantages over chloroquine and other monoquinolines. 29 
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b CH2CH(CH3) b HN(CH2hO(CH2hO(CH2)NH 
c trans-! ,2-cyclohexy! c HN(CH2hO(CH2)40 (CH2)NH 
d (CH2») d HN(CH2»)O(CH2)20(CH2)P(CH2hNH 
e (CH2)4 e HN(CH2hNH(CH2)2NH 
f (CH2)s f HN(CH2»)NH(CH2)2NH 
g (CH2hCH(CH3)CH2 g HN(CH2»)NH(CH2h NH 
h (CH2)6 h HN(CH2)3NCH)(CH2)3NH 
(CH2)7 I HN(CH2)6NH(CH2)6NH 
J (CH2)s 
r\ 
k (CH2l9 
j HNCH2CH2N N 
"--I 
(CH2)iO 
Figure 6. Examples ofbisquinoline derivatives 
Riechmann and co-workers 30 have recently discovered that the four quinoline Mannich base 
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derivatives (98 a-d) possess marked and prolonged antimalarial activity, while triazoloquinolines, 
such as 99, have been shown to exhibit antibacterial, anti-allergic, antidepressant and anti-
anythmic effects.'4 
CH2NR2 O~ 
"'" 
NH OH 0 
~ # }=1 y CH2NR2 # ~ X N 
98 a-d Ct;H5 99 
X Y NR2 
a CF3 H pyrrolidinyl 
b CF3 H piperidinyl 
c CF3 H 4-methylpiperazinyl 
d CI Me piperidinyl 
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1.4. QUINOLONE ANTIBACTERIALS 
Fluoroquinolone antimicrobial agents were introduced into the chemotherapy of infections in the 
early 1960's during the search for improved antimalarial agents. At the time. little work was done 
to chemically modifY these compounds, and it was only in the 1980's that significant advances 
were made with this group of drugs 3 I The currently available fluoroquinolones, which include 
ciprofloxacin 101 and ofloxacin 102, provide major advances over the use of the original DNA 
gyrase inhibitor, nalidixic acid 100. N orfloxacin 103 shows little binding to gyrase or DNA alone, 
but significant amounts of the drug bind to the gyrase-DNA complex. Ciprofloxacin 101 is used 
worldwide to treat a broad variety of bacterial infections, including those in the urinary tract, 
0 0 
C02H F ?7 C02H ?7 
'" r N ""'- N N N ~ rm~ ~ 
Nalidixic Acid 100 Ciprofloxacin 101 
0 
0 
F ?7 C02H F ?7 C02H 
r N ""'- N r N ""'- N ~ O~ rm~ ~~ 
Ofloxacin 102 Norfloxacin 103 
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respiratory system and skin and soft tissue, as well as those involving sexually transmitted 
diseases. 32 While ciprofloxacin is the most effective of the currently available fluoroquinolones , 
it has a number of limitations which have provided an impetus for the search for new analogues. 
Ciprofloxacin has relatively low intrinsic potency against many Gram-positive organisms, 
including Streptococus pneumoniae, and is not very potent against the anaerobic organisms which 
are commonly encountered in intra-abdominal infections." Based on their mechanism of action 
on the bacteria-specific DNA gyrase, the quinolones may be classified as DNA-directed drugs of 
comparatively low toxicity.]] 
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1.5. STYRYLQUINOLINE DERIVATIVES AS HIV-l INTEGRASE 
INHIBITORS 
New, potential HIV -I integrase inhibitors have been designed, in which a quinoline substructure 
is linked, by means of an ethylenic spacer, to an aryl nucleus possessing various dihydroxy 
substitution patterns.34 Although the most active compounds contain the catechol structure, this 
moiety is not essential for activity since the most potent analogue l04i (Figure 7) lacks this group, 
thus implicating a different pharmacophore. The most promising styrylquinolines inhibit HIV-
lintegrase in vitro at rnicromolar or submicromolar concentrations and block HIV replication in 
CEM cells, with no significant cellular toxicity in a 5-day period 3 4 These new styrylquinolines 
may provide lead compounds for the development of novel antiretroviral agents for AIDS therapy, 
based upon the inhibition of HI V -I integrase. They might also be used to elucidate the mechanism 
of inhibition of this enzyme, e.g. they could serve as candidates for co-recrystallization studies with 
HIV -I integrase34 
Styrylquinolines, in general, and 2-(p-dimethylaminostyryl)quinolines and their quaternary iodides, 
in particular, have been the subject of extensive screening for tumour inhibiting properties, and 
for bactericidal and fungicidal properties. I 
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C02H H C02H H 
Figure 7. Examples of Styrylquinoline derivative: 
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1.6 QUINOLINE DYES 
Although many commercially valuable dyestuffs contain fused quinoline rings, quinoline yellow 
(quinophthalone) 107 is the only simple quinoline derivative to find such use, and it is readily 
obtained by the condensation of quinaldine 105 and phthalic anhydride 106 (Scheme 18).' 
o 
o 
v 
o 
105 106 107 
Scheme 18 
The cyanines (e.g. 110 and 112; Scheme 19 ) are an important group of dyes used for improving 
the colour sensitivity of photographic emulsions. They are useless as fabric dyestuffs owing to 
their instability to light but, in 1875, Vogel found thatthey could sensitize photographic emulsions 
to green light.3 The reason for this is that they contain one of the few organic structures capable 
of absorbing light in the visible and infrared regions and transferring the energy to a photographic 
emulsion as a 'latent image ' of activated silver halide crystals. In this way, the sensitivity of a 
silver bromide emulsion can be extended from its natural position in the ultraviolet and blue 
regions of the spectrum to the green, red and near-infrared regions . With suitable combinations 
of these dyes the sensitivity can be balanced throughout the visible spectrum to give 
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'panchromatic ' emulsions. The dye, cyanine llO (a green sensitizer), is formed by base-catalyzed 
condensation of the quaternary ethiodides of2-methylquinoline 108 and 4-methylquinoline 109; 
the dye, pinacyanolll2 (a red sensitizer) , is formed similarly from l-ethyl-2-methylquinolinium 
iodide III and ethyl orthoformate (Scheme 19). 
(I , 
"""'" """'" KOH 'I 
+ (I ~ • Et-N + ~ + -'" + N-Et (alcoholic) N 
I 
Et r r 
108 109 N 
\ 
11 0 (cyanine) Et 
~ """'" """'" """'" I + HC(OEth pyridine( dry~ I ~ ~-'" ~ + -'" ~ 
I N N I I Et r Et Et 
111 112 (pinacyanol) 
Scheme 19 
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1.6 AIMS OF THE PRESENT INVESTIGATION 
Previous work in our laboratories has demonstrated the potential of the Baylis-Hillman reaction 
in the construction of heterocyclic systems. Thus, pyridine-2-carbaldehyde-derived Baylis-Hillman 
products have been used as precursors for the synthesis of indolizine derivativesJ5. 36 in a reaction 
which involves the thermal cyclisation of the acetylated Baylis-Hillman products. The Baylis-
Hillman reaction has also been used to access oxygen-containing heterocycles, viz., chromenes, 
coumarins and numerous derivatives thereo[.l'-4J In cognate studies, attention has been given to 
the chemoselective formation of chromene and coumarin systems. Extension of the general 
methodology to the synthesis of quinoline derivatives was initiated at Rhodes by Familoni,'4 and 
the present investigation was undertaken to extend, and further explore, applications of the Baylis-
Hillman reaction in the synthesis of quinoline derivatives. Specific objectives in this study have 
included the following. 
1. The synthesis of a range of Baylis-Hillman products, derived from varIOUS 2-
nitro benzaldehyde derivatives and activated alkenes. 
2. Optimisation of the reaction conditions for the catalytic reduction and cyclisation of these 
Baylis-Hillman products to quinoline derivatives. 
3. An investigation of the use of stannous chloride as an alternative reagent for the reductive 
cyclisation of the Baylis-Hillman products. 
4. The development of convenient methods for the interconversion of the quinol ine 
derivatives and their N-oxides isolated from some of the above reactions. 
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2. DISCUSSION 
In the discussion which follows, attention will be given to the preparation of Baylis-Hillman 
products as quinoline precursors (Section 2.1) and their reduction to quinoline derivatives:- i) 
via catalytic hydrogenation with palladium-on-carbon as catalyst (Section 2.2.1) and ii) using 
stannous chloride (Section 2.2.2). Finally, the interconversion of the quinoline derivatives and 
their N-oxides will be considered in Section 2.3. 
2.1 PREPARATION OF BAYLIS-HILLMAN PRODUCTS 
Carbon-carbon bond formation is one of the most fundamental reactions in organic chemistry, 
and the development of efficient and selective methods for the construction of these bonds is an 
exciting and challenging endeavour. The Baylis-Hillman reaction permits the formation of such 
carbon-carbon bonds between the IX-position of an activated alkene and a carbon electrophile 
containing an electron-deficient Sp2 carbon atom; the reaction proceeds in the presence of a 
suitable catalyst (typically, a tertiary amine) and affords multifunctional products (Scheme 
20).42,43 In the most recent review of this reaction, 45 it has been called the Morita-Baylis-
Hillman reaction in recognition of early contributions by Morita.46 The most commonly 
employed activated alkenes are acrylic esters, but a number of other systems" couple with 
aldehydes to give the analogous Baylis-Hillman products. Examples of these include methyl 
vinyl ketone and other vinyl ketones, acrylonitrile, diethyl vinylphosphonate, phenyl vinyl 
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sulfone and acrolein42.48 The reaction thus involves three components, viz. , an electrophile, an 
activated alkene and, typically, a tertiary amine catalyst. There are various catalysts that can be 
used but, in this project, 1,4-diazabicyclooctane (DABCO) was used exclusively. 
Tertiary amine 
R XH Rl~EWG 
113 114 115 
EWG = Electron Withdrawing Group 
Scheme 20 
Mechanistic studies 42 have indicated that the reaction proceeds as illustrated in Scheme 21. The 
reaction is initiated by conjugate addition of the nucleophilic catalyst (e.g. DABCO 116) to the 
activated alkene 117 resulting in the formation of a zwitterionic enolate 118, which subsequently 
attacks the aldehyde 119 (in a nucleophilic addition step) to produce the zwitterionic adduct 120, 
which undergoes elimination to afford the final Baylis-Hillman product 122 and release the 
catalyst, DABCO. Recent computational studies49 suggest that the elimination proceeds via an 
ElcB mechanism involving formation of the intermediate enolate anion 12l. 
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Scheme 21 
In research conducted in our laboratories, Bode and Kaye 35,36 have demonstrated applications 
of the Baylis-Hillman reaction in the synthesis of substituted indolizines 125 from pyridine-2-
carbaldehydes 123 (Scheme 22), and in analogous reactions of salicylaldehydes, Kaye and 
Robinson 37,39 have uncovered a cascade oftransfonnations involving the fonnation of chromene 
129 and coumarin 130 derivatives (Scheme 23). The chromenes result from conjugate addition 
of the nucleophilic phenolic oxygen (X=O) to the double bond of the Baylis-Hillman product 
128, whereas the coumarins result from nucleophilic attack on the carbonyl carbon. In view of 
these observations, the use of 2-aminobenzaldehydes 128 (X=NH) as electrophiles in Baylis-
Hillman reactions was expected to result in the corresponding quinoline derivatives 131 and 132 
(Scheme 23) 
39 
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As mentioned earlier (Section 1.2), numerous quinoline syntheses have been developed and, in 
one of them, the Friedlander synthesis, 2-aminobenzaldehyde is used as a precursor. The 
disadvantage of the Friedlander methodology, however, is the relative inaccessibility of the 
substituted 2-aminobenzaldehydes which are required for the construction of substituted 
quinolines. Furthermore, aldehyde electrophilicity is one of the over-riding factors in the 
Baylis-Hillman reaction and 2-nitrobenzaldehydes were expected to be more electrophilic than 
2-aminobenzaldehydes. Consequently, a method was planned wherein 2-nitrobenzaldehyde is 
used as the substrate and reductive cyclisation of the resulting Baylis-Hillman product 136 
affords the target quinoline via the 2-amino synthon 135 (Scheme 23a). The investigation was 
begun in our laboratories by Familoni44 and, in the present study, this work has been extended, 
and some of the results have already been published." 
~COzR OH 
~N) 0 OH 0 
OR FGI 
""" 
OR 
>1 # N02 
I """ 
133 H > 1 
135 136 
0 
ijBaYlis-Hillman 
0 
""" 
H r OR + # N02 127 137 
Scheme 23a: Retrosynthetic analysis for expected quinoline derivatives 
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A range of Baylis-Hillman products 140 a-p were synthesised as quinoline precursors by reacting 
a series of 2-nitrobenzaldehyde derivatives 138 with activated alkenes 139 in the presence of 
DABCO (Scheme 24). IH NMR spectroscopy and thin layer chromatography of the crude 
reaction mixtures revealed the formation of the complex mixtures of products. 
R2 R2 OH 
R3 CHO R3 
""" 
Ri 
""" IrRi DABCO + » ~ 
R4 ~ N02 
R4 N02 
R5 R5 
138 139 140 a-p 
R I R2 R] R4 R 5 
a C02Me H H H H 
b C02Et H H H H 
c COMe B H H H 
d CN H H H H 
e SO:!Ph H H H H 
f SO]Ph H H H H 
g COH H H H H 
h COEt H H H H 
i C0 2Me H OMe OMe H j COMe H OH H H 
k CO:!Me H H N02 H I C02Me H Cl H H 
m COMe H -OCH2O- H 
n COE! Cl H H H 
0 COE! H H H OMe 
p COE! NO:! H H H 
Scheme 24 
Yields for these reactions ranged between 7 and 63 % (Table 1; p.47), with acrolein giving the 
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lowest yield. Reaction times were between one and five weeks and the mole ratio of the reactants 
was:- aldehyde: activated alkene: DABCO :: 1: 1 :0.05. The Baylis-Hillman products 140 a-p were 
fully characterised by spectroscopic (NMR and IR) and elemental (high resolution MS) anlysis . 
Representative 'H, COSY and HMQC NMR spectra are illustrated for methyl 3-hydroxy-2-
methylene-3-(2,4-dinitrophenyl)propanoate 140k in Figures 8-10. Various structural features 
are clearly evident in the 'H NMR spectrum of this compound. Thus, the methoxy and hydroxyl 
groups resonate at 3.75 and 3.46 ppm respectively, while the vinyl proton signals at ca 5.7 and 
6.3 ppm are characteristic of this class of compounds. Coupling is observed between the 
hydroxyl proton and the vicinal proton - an interaction clearly apparent in the COSY spectrum 
(Figure 9). The number of carbon atoms in the compound corresponds exactly with the number 
of C-13 signals in the \3C NMR spectrum (two of the signals almost coincide but, on expansion 
of the spectrum, are clearly evident at 127.6 and 127.7 ppm), and the correlations between these 
carbons and the protons in compound 140k are confirmed by the HMQC data (Figure 10). 
i r r-
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Figure 8: 400 MHz 'H NMR spectrum of Baylis-Hillman product 140 k in CDCl3 
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Figure 9. 400 MHz COSY spectrum of the Baylis-Hillman product 140k in CDCl, 
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Figure 10. 400 MHz HMQC spectrum of the Baylis-Hillman product 140k in CDCl, 
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2-Nitrobenzaldehyde derivatives which contain other, electron-releasing substituents are 
expected to show reduced reactivity in the Baylis-Hillman reaction due to the decreased 
electrophilicity of the aldehyde function . Thus, delocalisation of lone pair electrons from the 
para-methoxy group should decrease the reactivity of the dimethoxy analogue 138i (reflected 
by the canonical structures 141 and 142; Figure 11) and this is presumably reflected in the low 
yield observed for this substrate (14 %). The apparently sluggish reactivity of the dinitro 
analogue 138k, however, was surprising, given the presence of the additional electron-
withdrawing substituent. From the results obtained for these reactions, vinyl ketones and a,p-
unsaturated carboxylic esters generally appear to exhibit greater conversion efficiencies than the 
other vinyl systems examined. 
O~ 0 -
MeO 
?Y MeO 
I:) H R .. • MeZ) ~ N~ + MeO 
141 142 
Figure 11: Delocalisation of lone-pair electrons in the 
dimethoxy substrate138i 
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Optimisation studies were undertaken to improve the yields of the Baylis-Hillman products, and 
several reaction variables, such as the concentration of the reagents, the catalyst and the reaction 
time were examined. After many attempts to establish the optimum molar ratio of reactants, the 
best results were obtained with an aldehyde: activated alkene: DABCO mole ratio of I: 1.5: 0.05 . 
Having the aldehyde as the limiting reagent and increasing the mole ratio of the activated alkene 
proved particularly effective, since the use of equimolar ratios of these two components always 
resulted in the recovery of unreacted aldehyde. The improved yields obtained for selected 
reactions is evident from a comparison of the data in Tables 1 and 2. Excellent yields were 
obtained for four of the products 140b, c, k and 0; the reaction of2-chloro-6-nitrobenzaldehyde 
138n with ethyl vinyl ketone, however, gave a disappointing yield of the 5-chloro analogue 140n, 
while 2,6-dinitrobenzaldehyde failed to react under these conditions. The lack of reactivity of 
2,6-dinitrobenzaldehyde may be attributed to steric hindrance about the carbonyl group by the 
bulky nitro group, which inhibits nucleophilic attack at the carbonyl centre. 
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Table I. Yields for the Baylis-Hillman products 140 a-m 
R2 OH 
R3 
~ 
Rl 
I 
R4 .# N02 
RS 
Compd. R I R 2 R 3 R 4 R S Yieldt / 
% 
140a C02Me H H H H 57 
l40b C02Et H H H H 46 
140c COMe H H H H 47 
140d CN H H H H 44 
140e S02Ph H H H H 32 
140f S03Ph H H H H 27 
140g COH H H H H 7 
140h COEt H H H H 63 
140i C02Me H OMe OMe H 14 
140j COMe H OH H H 22 
140k C02Et H H NO} H 26 
1401 CO}Me H Cl H H 52 
140m COMe H -OCHP- H 33 
t Yields given in this table and elsewhere are for chromatographed products 
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Table 2. Yields for selected Baylis-Hillman products 140 following optimisation studies 
R2 OH 
R3 
""" 
Rl 
I 
R4 # N~ 
R5 140 
Compd. Rl R2 R' R' R' Yield I % 
140b C02Et H H H H 95 
140c COMe H H H H 60 
140k C02Me H H NO] H 92 
140n COEt Cl H H H 25 
1400 COEt ~ H H OMe 89 
" 140p COEt NO, H H H 0 
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2.2 REDUCTIVE CYCLIZA TlON OF THE BAYLIS-HILLMAN PRODUCTS 
The next step in the synthesis of the quinoline derivatives involved reduction of the artha-nitro 
group to generate the nucleophilic ortho-amino group required for cyclisation. Initially, the 
reduction was effected by catalytic hydrogenation; subsequently, attention was given to the use 
of stannous chloride as the reducing agent. It was, of course, recognised that cycJisation of the 
ortho-amino derivative could, in principle, involve:-
OH 
R' N02 
140 
R' 
0 
R 
reduction 
.. 
R ~ alkyl 
nucleophilic 
addition 
OH 
o 
N R 
146 
OH 0 
""" J) R~,", I 
# conjugate-
NH, I addition R' 
R' .. - II 
143 
path II 
R ~ alkoxy 
nucleoph ilic 
acyl substitution 
145 
""" 
# 
144 
OH 
N 
I 
H 
OH 
N 
I 
H 
o 
Scheme 25: Possible cyclisation pathways for theo-amino derivatives 
0 
I 
H 
(i) conjugate addition to the (X,p-unsaturated carbonyl system, following path I (Scheme 25) 
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and/or 
(ii) nucleophilic attack at the carbonyl carbon, following path II, with the vinyl ketones (R= alkyl) 
undergoing nucleophilic addition and the esters (R=alkoxy) undergoing acyl substitution. 
Subsequent dehydration of the primary cyclisation products 144, 145 and 146 would then afford 
the corresponding, unsaturated derivatives. 
2.2.1 Catalytic hydrogenation 
When selected Baylis-Hillman products 140a-m were hydrogenated at atmospheric pressure, 
using a 10% palladium-on-carbon catalyst, no compounds arising from conjugate addition (path 
I; Scheme 25) were, in fact, isolated. The conjugate addition pathway (path I) would have 
afforded the tetrahydroquinolines 144 (and their dehydrated derivatives), and the 'HNMR spectra 
for such compounds would clearly indicate the presence of the 3-substituent (RC=O), while the 
DC NMR spectra would exhibit a carbonyl signal at ca. 170 ppm. No products with such NMR 
characteristics were isolated, and it became apparent that regioselective cyclisation involving 
attack at the carbonyl carbon (path II) was favoured. For the esters (R= alkoxy; Scheme 26) it 
became clear that cyclisation involved nucleophilic acyl substitution to afford products of type 
145,149 and 150, while the vinyl ketones (R=alkyl) gave rise to condensation products of type 
147 and 148 via nucleophilic addition at the carbonyl centre. 
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Scheme 26. Reagents and conditions: i) Hb Pd-C, r.t 
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2.2.1.1 Nucleophilic acyl substitution 
From spectroscopic analysis it was evident that reductive cyclisation of the Baylis-Hillman 
esters proceeds via the nucleophilic acyl substitution pathway to give, in addition to the initial 
4-hydroxy quinolones 145, the quinolones 149 and their hydrogenated derivatives 150 (Scheme 
26; Table 3). 
Structure Compd. R' Yield / % 
R''CC( 1493 H 15 
# N 0 CI II 1491 
OH 
R'''C 1453 H 18 
N 0 1451 CI 9 
R'''CC( 1503 H 41 
# N 0 
1501 CI 24 
Table 3. Yields for the nucleophilic substitution reactions (Path II; Scheme 25) 
The formation of these products can be rationalised in terms of the mechanism outlined in 
Scheme 26. Thus, after the nitro group has been reduced, the resulting, nucleophilic amino group 
attacks the carbonyl carbon to give the "tetrahedral intermediate". Loss of the alkoxide leaving 
group then affords the diastereomeric 4-hydroxy quinolones 145, and subsequent dehydration and 
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reduction of the resulting endocyclic double bond then leads to products 149 and 150. The 
dehydration step has been demonstrated previously by Familoni," who treated the diastereomeric 
system 145 (R=H) with p-toluenesulfonic acid in refluxing toluene to obtain the conjugated, 
achiral3-methylquinolone 149; (R= H). The structural differences between the substrates 140 and 
the products 145, 149 and 150 are clearly evident in their 'H NMR spectra. Figures 12a and b 
illustrate the differences between compounds 140a and 150a. Thus, the characteristic vinylic 
signals of the Baylis-Hillman product between 5.5 and 6.5 ppm and the methoxy singlet at 3.75 
ppm are clearly absent in the spectrum of compound 150. The spectrum of the 
tetrahydroquinoline 150a, reveals a methyl doublet at 1.25 ppm and the methine and methylene 
multiplets between 2.5 and 3.05 ppm. 
OH 0 
_ _ ____ . ___ .-!u.u'-'-__ ..Ju\..--J\. ___ --'""' 
~~r1~1 I• • ~ . 
Figure 12a. 400 MHz 'H NMR spectrum ofth Baylis-Hillman product 140a in CDCI] 
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Figure 12b. 400 MHz 'H NMR spectrum of the tetrahydroquinoline 150a in CDCI] 
2.2.1.2 The nucleophilic addition pathway 
In the case of the vinyl ketone derivatives 140 (R=alkyl), reduction of the nitro group and 
nucleophilic attack of the resulting amino group at the carbonyl carbon gives the "tetrahedral" 
intennediate (Scheme 26; R=alkyl). Protonation and elimination of two molecules of water then 
gives the aromatic quinolines 147, which were fully characterised by spectroscopic (,H, "C, 
HMQC and COSY NMR and IR) and elemental (high resolution MS) analysis. The COSY and 
HETCOR NMR spectra for compound 147h (R =CH,CH3) are illustrated in Figures 13 and 14. 
The COSY spectrum clearly shows the coupling between CH2 and CH] protons, while the 
HETCOR spectrum shows the expected correlation between the carbons and the protons. 
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Figure 13. HMQC spectrum of the quinoline derivative 147h in CDCI] . 
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Figure 14. 400 MHz COSY spectrum of quinoline derivative 147h in CDCl
,
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This pathway, in fact, typically afforded two products, the quinoline 147 and its N-oxide 148 
(Scheme 26). The isolation of N-oxides from these reactions was initially confusing, since the 
N-oxides 148 have very similar 'H and 13C NMR spectra to the corresponding quinoline 
derivatives 147, and in EI mass spectrometry, ready loss of an oxygen atom from the N-oxide 
affords the quinoline radical cation, which was initially viewed as the molecular ion rather than 
as a fragment. In the apparent absence of any published data, the NMR spectra could not be used 
to establish unambiguously which compound was which. The N-oxides were finally 
characterised by high resolution F AB mass spectrometry (which confirmed the presence of an 
oxygen atom) and by the presence of the IR N-O absorption band at ca. 1271 em". The 'H 
NMR spectra of the quinoline 147h and quinoline N-oxide 148h are illustrated in Figure 15. The 
8-H nucleus in the quinoline N-oxide is de shielded by the positively charged nitrogen atom and, 
Structure Com pd. RI R2 R3 R4 Yield/'" 
RXXX
R2 147h Et Me H H 34 
R4 I #' N RI 147c Me Me H H 20 
147m Me Me -OCH2O- 26 
RXXX
R2 148f H S03Ph H H 5 
I 
#' + 148c Et Me H H 39 R4 N RI 
I 
O' 
148h Me Me H H 52 
Table 4. Quinolines and quinoline N-oxides obtained via the nucleophilic addition pathway 
56 
Discussioll 
hence, resonates downfield (at ca. 8.7 ppm) of the corresponding nucleus (at ca. 8.0 ppm) in the 
quinoline derivative. The quinolines and corresponding N-oxidcs obtained in the present study 
are detailed in Table 4. 
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Figure 15.400 MHz 'H NMR spectra of the quinoline 147h and the corresponding quinoline N-
oxide 148h in CDCl3 
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Fonnation of the quinoline N-oxides 148 is attributed to cyclisation of an incompletely reduced 
nitro species. Illustrated below is the generally accepted mechanism for the reduction of the 
nitro group (Scheme 27),50 and it is apparent that either of the intennediates 158 or 159 could, 
in principle, act as a nucleophile, attacking the carbonyl carbon before reduction to the amino 
group is complete. The fact that quinoline N-oxides were always isolated in higher yields than 
the corresponding qui no lines is consistent with relatively rapid cyclisation prior to complete 
fonnation of the amino group. 
In two of the cases examined, reduction of the Baylis-Hillman products ,viz. , the nitrile 140d and 
the sulfone 140e, afforded the corresponding acyclic derivatives 161d and 161e respectively, 
(Scheme 28). 
o 
+ 1' metal 
Ar- N .. 
'0-
151 
Ci 
+ / 
Ar-N 
. ' 0-
152 
H+ 
Ar- N-O-H .... 1---- Ar-N- O-
157 156 1 metal 
H 
H+ I 
----1 .. ~ Ar-N-O-H -Ar-N- O-H 
158 159 
Scheme 27 
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These products arise from reduction of the double bond, and it seems that cyclisation involving 
conjugate addition at the acrylonitrile or vinyl sulfonyl moieties is not favoured. The formation 
of these acyclic compounds was evident from their proton and carbon-l 3 NMR spectra. The 
compounds are produced as diastereomeric mixtures due to the presence of two stereo centres, 
with resultant doubling of proton and carbon-l 3 NMR signals. 
OH OH 
-:P 
R R R Yield /% 
-:P 
H2, Pd / C d CN 37 
~ • N~ ~ e S~Ph 31 NH2 
140 161 
Scheme 28 
The IR spectrum of compound 161d clearly shows the eN stretching band at 2244 cm" (Figure 
16). The 'H NMR spectra of the substrate 140d and product 161d are illustrated in Figure 17; 
the disappearance of the substrate vinyl proton signals between 5.8 and 6.3 ppm and the 
appearance of the (doubled) methyl signal in the product spectrum clearly confirms the proposed 
transformation. The acyclic products (161d and 161e) were fully characterised. 
59 
" 
" 
" 
" 
.. 
.. 
.. 
.. 
• 
" 
" 
)1.0. 1 
" 
" 
" 
\ 
\ 
";' 0' I I 
1>" ., 
OH / " "', I ° ,,\.':'" "", ,::: : ctr~ I C1' "L I ~ U'~., 1'H, 
"0.0 
Figure 16. The IR spectrum of compound 161d in nujol 
, , , 
DP' 
" " 'I 0 
DP' 
"I' 
10 
, 
10 
, " 9 
, 
9 
,. I' 
a 
'I it 
B 
Ii 
.1--- ~ r 
" 7 
, I " " I ; I 
7 6 
, 
6 
011 
_ 1(1', 
r""'YI Y II i ,i 
~1'0: 
, 
5 " i "i" , J 
1"""'"1''''' 'I 5 , J 
''' .. 
I' 
2 
I' 
2 
Discussion 
.r 
I 
'i' "I"" 
I o 
'i Ii" "'i"'" 
I 0 
Figure 17. 400MHz 'H NMR spectra of the Baylis-Hillman product 140d and its reduced 
derivative 161d in CDCl3 0 
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2.2.2 Reduction with Stannous Chloride 
The reduction of aryl nitro groups may be achieved with a variety of reagent systems"-", and it 
was decided to explore the use of stannous chloride as an alternative reducing agent l4 Ethanol 
is typically used as the solvent with this reagent. but when the reaction was applied to the 
reduction of the methyl ester 140a, two unexpected observations were made. Firstly, cyclisation 
appeared to favour conjugate addition to afford the dihydroquinoline (Scheme 29) rather than the 
nucleophilic acyl substitution pathway observed on catalytic hydrogenation of the same substrate; 
subsequent extension of the reaction to other Baylis-Hillman products revealed that regioselective 
cyclisation to 3-substituted dihydroquinolines was, in fact, generaL Secondly, Snel2 reduction 
ofmethyI3-hydroxy-2-methylene-3-(2-nitrophenyl)propanoate 140a in ethanol afforded the ethyl 
ester 162b, and it was clear that stannous chloride was acting as a Lewis acid, catalysing 
trans esterification of the methyl ester in the presence of ethanoL The ethyl ester 162b was fully 
""" """ 
c:Y 
47\; SnCll ·2Hl O 
# MeOH ~ N 0 
H 
149a 
OH o 
OCH) 
SnClz·2H,0 I ~ 
EtOH 
140a 1 SnClz·2H10 
MeOH 0 
I 
~ ~ OMe 
N 
H 
Scheme 29 
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characterised using IR, MS and NMR spectroscopic techniques. The COSY spectrum (Figure 
18) clearly reveals the coupling between the methyl (triplet at 0 1.30 ppm) and methylene (quartet 
at 0 3.60 ppm) nuclei of the ethyl group. To avoid transesterification, methanol was used as the 
solvent instead of ethanol, and the methyl ester 162a was obtained in 50% yield. 
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Figure 18: 400 MHz COSY spectrum of the methyl ester 174 
A third, unexpected observation was made when the reaction was extended to other substrates. 
Baylis-Hillman esters gave rise to the corresponding I ,2-dihydroquinolines whereas the ketone 
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analogues gave the N-hydroxy analogues 163 (Scheme 30). The presence of an extra oxygen 
atom (and, hence. the N-hydroxy moiety) in these latter compounds was confirmed by FAB MS 
analysis. In the case of the Baylis-Hillman ketone 140c, however, the presence of the methoxy 
group at C-8 appears to inhibit formation of the N-hydroxy product, and the corresponding 1,2-
dihydroquinoline 1620 was isolated. To our knowledge, all of the 1,2-dihydroquinoline 
derivatives synthesised in this project are new. An ethyl dihydroquinoline-3-carboxylate 
derivative has been reported by Blicke et aI. , II but there is some ambiguity as to the position 
OH 0 
RI R2 R3 
~ Rl a OMe H H 
b OEt H H 
R2 
,4/ 
N02 C Me H H 140 h Et H H RJ 
SnCI2·2H2O 
0 Et H OMe 
MeOH or EtOH 
For Rl ~ alkoxy For Rl ~ alkyl 
(or RI ~ alkyl; R3 ~ MeO) 
0 0 
~ Rl ,.?" ~ Rl 
R2 N 162 R2 ~ N 
I I 163 
R3 H R3 OH 
RI R2 R3 RI R2 R3 
a OMe H H C Me H H 
b OEt H H h Et H H 
o Et H OMe 
Scheme 30 
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I 
of the double bond: the authors suggest probable formation of the dihydro isomer. 
In the 13C NMR spectrum of compound 162a, the methylene signal overlaps the solvent (CHCI,) 
signal at ca. 77.0 ppm but its presence is confirmed by the DEPT spectrum; in the 13C NMR 
spectra of the analogous compounds 162b and 1620, the methylene nuclei resonate at ca. 77.5 
ppm. Yields for these reactions ranged between 14 and 54 %. It is quite possible that the 
conversion efficiences were, in fact, higher, but considerable difficulty was encountered in 
attempting to extract the product from the emulsions which formed when the reaction mixtures 
were added to ice. 
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2.3. INTERCONVERSION OF QUINOLINE DERIVATIVES AND THEIR 
N-OXIDES 
The reduction of N-oxides has been achieved using ammonium formate as a catalytic hydrogen 
transfer agent,56 but recent work57 has shown that phosphorus tribromide is a better reducing 
agent. m-Chloroperbenzoic acid (MCPBA), on the other hand, has been found to be an effective 
oxidising agent for converting amines to their N-oxides.'8 Consequently, the use of PBr3 or 
MCPBA was investigated for the selective formation of eilher the free quinoline derivatives or 
their N-oxides respectively .. Following some exploratory studies, 2,3-dimethylquinoline 147c, 
isolated from reductive cyclisation of the Baylis-Hillman product 140c using catalytic 
hydrogenation, was oxidized with MCPBA in CHCl3 to afford the quinoline N-oxide 148c in 
good yield (78 %) (Scheme 31). In the reverse transfonnation, 2,3-dimethylquinoline N-oxide 
148c, was reduced with PBr3 in DMF to afford 2,3-dimethylquinoline 147c in 76 % yield. 
-::?' 
"""'" 
-::?' 
"""'" MCPBA 
• 
~ 0 CHCI3 ~ + 0 N N 
148c 
I 
147c o· 
-::?' 
"""'" 
-::?' 
"""'" 
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• ~ + 0 DMF ~ 0 N N I 
148c 0 147c 
Scheme 31 
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The 'H NMR spectra of the quinoline 147c and its N-oxide 148c are illustrated in Figure 19.The 
quinoline derivative 147c exhibits two methyl signals between /) 2 and 3 ppm, while the 4-H 
nucleus resonates as a singlet at /) 7.7 ppm. The quinoline N-oxide 148c exhibits similar 
chemical shifts except in the aromatic region where the deshielded 8-H nucleus resonates as a 
doublet downfield (at ca. 8.7 ppm) of the corresponding proton (at ca. 8 ppm) in the spectrum 
of the quinoline derivative 147c. As mentioned earlier, this deshielding is due to the positive 
charge on the nearby nitrogen atom. 
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Figure 19: 'H NMR of quinoline 147c and quinoline N-oxide 148c in CDCl3 
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To avoid having unnecessary steps, it was decided to explore i) reduction and ii) oxidation of a 
mixture of the quinoline derivative 147c and itsN-oxide 148cto demonstrate "one-pot" formation 
of either the quinoline or the quinoline N-oxide. Thus, a mixture (I: 1.63 molar ratio) of the 
quinoline 147c and the quinoline N-oxide 148c (obtained via catalytic reduction of the Baylis-
Hillman product 140c) was divided into two portions. One portion of the mixture was reduced 
with PBr) and, since only theN-oxide is susceptible to reduction, the quinoline 147c was the only 
product isolated from the reaction mixture (Scheme 32). The other portion was oxidized using 
MCPBA as an oxidising agent and,in this case, oxidation of the quinoline present in the mixture 
appeared to occur quantitatively, permiting isolation of the N-oxide 148c as the sole product. 
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-""" 
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This approach clearly solves the problem of selectivity in this reaction. When the synthesis of 
quinolines is required, PBrJ can be added to the mixture after the catalyst has been filtered off, 
and any quinoline N-oxide present will be reduced to the quinoline. On the other hand, MCPBA 
may be added to the reaction mixture (after removal of the catalyst) when the quinoline N-oxide 
is required. 
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2.5. CONCLUSION 
During the course of this research, a range of Baylis-Hillman products has been successfully 
prepared from 2-nitrobenzaldehyde derivatives and various activated alkenes. Reductive 
cyclisation via catalytic hydrogenation has been shown to afford, depending on the nature of the 
Baylis-Hillman product, either quinoline, quinoline N-oxide or quinolone derivatives, and the 
structures of these products have been established unambiguously using NMR, high resolution 
MS and, in some cases, FAB MS spectroscopy. Attention has been given to optimising the 
yields in these reactions, and the use of stannous chloride as an alternative reagent to effect 
reductive cyclisation has been explored. Use of this reagent, however, resulted in the unexpected 
formation of different products, viz. , 1,2-dihydroquinoline derivatives, arising from cyclisation 
via conjugate addition. In contrast, under catalytic hydrogenation conditions, cyclisation 
involves nucleophilic attack at the carbonyl carbon resulting in condensation or acyl substitution. 
The different modes of attack thus provide scope for the chemoselective synthesis of quinoline, 
quinoline N-oxide and quinolone derivatives, on one hand, and the synthesis of 1,2-
dihydroquinoline derivatives on the other, the chemoselectivity being determined by the 
appropriate choice of substrate and reducing system. 
Methods for effecting the efficient interconversion of the quinoline and quinoline N-oxide 
derivatives have been successfully optimised; reduction of the N-oxide to the quinoline was 
achieved using PBr] and the reverse transformation with MCPBA. Finally, the methods were 
successfully applied to mixtures of the quinoline derivative and its N-oxide. 
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It is apparent that the objectives of this investigation have been successfully addressed and the 
results have opened novel, efficient and chemoselective approaches to a very important class of 
heterocyclic compounds. 
Possibilities for future research in this area include:-
i, the use of other reducing systems to effect reductive cyclisation of the initial Baylis-Hillman 
products; 
ii, detailed investigation of the mechanistic basis of the observed regioselectivities; and 
iii, elaboration of the quinoline derivatives to pharmacologically active systems and, in particular, 
quinoline-based antimalarials. 
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EXPERIMENTAL 
3.1. GENERAL 
Melting points were determined using a Kofler hot -stage apparatus and are uncorrected. NMR 
spectra were run on a Bruker AMX400 spectrometer, and chemical shifts (0) are expressed in parts 
per million (ppm). NMR samples were, in most cases, dissolved in CDC13 Spectra recorded in 
CDC13 were calibrated using the solvent signal at 7.25 for IH and 77.0 for "C. IR spectra were 
recorded on a Perkin-Elmer Spectrum2000 FT-IR spectrometer. Low resolution mass spectra were 
obtained on a Finnegan Mat GCQ mass spectrometer and high resolution mass spectra on a Kratos 
MS 80RF mass spectrometer (Cape Technikon Mass Spectrometry Unit). 
Flash chromatography 59.60 was carried out using Merck silica gel 60 [particle size 0.040 - 0.063 mm 
(230 - 400 mesh)) and preparative layer chromatography (PLC) was achieved using Merck silica gel 
60 PF254 . Thin layer chromatography (TLC) was performed using precoated Merck silica gel F254 
plates, visualisation of the components being achieved by exposure to iodine or inspection under UV 
light. Methanol was dried under dry N2 using the procedure described by Perrin and Armarego. 61 
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3.2 SYNTHETIC PROCEDURES 
3.2.1. Preparation of Baylis-Hillman products 
Methyl 3-hydroxy-2-melhylene-3-(2-nilrophenyl}propanoale 140a 
A solution of 2-nitrobenzaldehyde (lOg, 66 mmol ), methyl acrylate (5 .9g, 68 mmol) and DABCO 
(0.354g, 3.16mmol) in chloroform (3 ml) was stirred at room temperature for 5 days.'1l The crude 
mixture was purified by flash chromatography [on silica; elution with hexane-EtOAc (3: I)] to afford, 
. as a pale green oil, methyI3-hydroxy-2-methylene-3-(2-nitrophenyl)propanoate 140a (8.96g, 54 %) 
(Found M+- Hp: 219.05329. Calc forC " H"NOs: M-Hp, 219.05316); Vm,., (nujol)!cm·' 3444 (OH) 
and 1710 (C=O); OH (400 MHz; CDC I,) 3.45 (I H, br s, OH), 3.83 (3H, s, CH3)' 5.71 and 6.34 (2H, 
2 x s, C=CH,), 6.18 (IH, s, CHOH), 7.45 (IH, t, Ar-H), 7.63 (lH, t, Ar-H), 7.73 (lH, d, Ar-H) and 
7.91 (lH, d, Ar-H); Dc (100 MHz; CDCIJ 52.1 (OCH), 67.5 (CHOH), 124.5 (C=CH,), 126.4 
(C=CH,), 128.6 (C-3'), 128.8 (C-6'), 133.4 (C-4'), 136.1 (C-I '), 140.7 (C-5'), 148.2 (C-2') and 166.4 
(C=O); mlz219 (M-H,o, II %) and 77 (100). 
'1l The reaction was generally monitored by TLC analysis and, when necessary, stirring was continued 
for a longer period. 
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Ethyl 3-hydroxy-2-rnethylene-3-(2-nitrophenyl)propanoate 140b 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-nitrobenzaldehyde (2 .0 g, 13 mmol), ethyl 
acrylate (1.37 g, 13.7 mmol ) and DABCO (0.071 g, 0.63 mmol). Work-up and flash 
chromatography [on silica; elution with hexane-EtOAc (3:1 )] gave, as a pale green oil, ethyl 2-
hydroxy-2-methylene-3-(2-nitrophenyl)propanoate 140b (1 .53g, 46 %) (Found M+ -Hp: 233.07069. 
Calc for C 12H IJNO, : M-H,o, 233.06881); vmax (nujol)!cm-' 3423 (OH) andl708 (C=O); OH 
(400MHz; CDCI)) 1.21 (3H, t, CH3) , 3.39 (lH, d, OH), 4.22 (2H, m, CH,), 5.72 and 6.36 (2H, 2xs, 
C=CH,), 6.17 (lH, d, CHOH), 7.47 (lH, t, Ar-H), 7.63 (IH, t, Ar-H), 7.74 (lH, d, Ar-H) and 8.13 
(lH, d, Ar-H); oe (100 MHz; CDCI3) 13 .7 (CH;), 61.0 (CH,), 66.9 (CHOH), 123.5 (C=CH,), 125.8 
(C=CH,) , 128.4 (C-3'), 129.0 (C-6'), 133.2 (C-4'), 136.2 (C-5'), 141.1 (C-I') , 148.1 (C-2') and 165.7 
(C=O); rnlz 233 (M'- H,O, 14 %) and 77 (100). 
4-Hydroxy-3-rnethylene-4-(2-nitrophenyl)butan-2-one 140c 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-nitrobenzaldehyde (5.0 g, 33 mmol ), methyl 
vinyl ketone (2.4 g, 34 mmol) andDABCO (0.18 g, 1.6 mmol). Work-up and flash chromatography 
[on silica; elution with hexane-EtOAc (3: I)] gave, as pale brown crystals, 4-hydroxy-3-methylene-4-
(2-nitrophenyl)butan-2-one 140c (4.2 g, 57 %), m.p. 133-136 DC (Found M+-H,O: 203.05776 . Calc 
for CII H IIN04:M-HP, 203 .06607); vmox!cm-' (nujol) 1703 (C=O); OH (400 MHz; CDCI3) 2.35( 3H, 
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s, CH), 3.53(lH, br s, OH), 5.77 and 6.15 (2H, 2xs, C=CH,), 6.20 (I H, s, CHOH), 7.45 (lH, t, Ar-
H), 7.65 (I H, t, Ar-H), 7.75 (I H, d, Ar-H) and 7.95 (lH, d, Ar-H); DC (I 00 MHz; CDCI3) 26.0 (CH), 
67.4 (CHOH), 124.6 (C=H,), 126.5 (C=CH,), 128.5 (C-4'), 128.8 (C-5 '), 133.5 (C- I'), 136.4 (C-3') , 
148.0 (C-2'), 148.8 (C-6') and 199.8 (C=O); m/z203 (M-HP, 2 %) and 161 (100). 
3-Hydroxy-2-methylene-3-(2-nitrophenyl}propanenitrile 140d 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-nitrobenzaldehyde (l0.0 g, 66 mmol), 
acrylonitrile (3.52 g, 66 mmol) and DABCO (0.37 g, 3.3 mmol). Work-up and flash chromatography 
[on silica; elution with hexane-EtOAc (3: I)] gave, as pale yellow crystals, 3-hydroxy-2-methylene-3-
(2-nitrophenyl)propanenitrile 140d (5.2 g, 38 %), m.p. 41- 44°C (Found M' -HP: 186.04305 . Calc. 
for C IOH8N,O): M-HP, 186.04293); vmox I em-' (nujol) 3396 (OH) and 2226 (CN); DH (400 MHz; 
CDC I) 3.32 (lH, br s, OH), 6.00 (IH, s, CHOH), 6.12 and 6.15 (2H, 2xs, C=CH,), 7.70 (IH, t, AI-
H), 7.75 (lH, t, Ar-H), 7.83 (IH, d, AI-H) and 8.02 (lH, d, AI-H); Dc (100 MHz; CDCI) 69.1 
(CHOH), 116.5 (C=CB,), 124.2 (C-I '), 125.1 (C=CH,), 129.1 (C-3'), 129.7 (C-6'), 132.1 (C-5'), 134.3 
(C-4'), 134.4 (C-2') and 147.9 (CN); mlz 186 (M'- HP, II %) and 77 (100). 
1-(2-nitrophenyl)-2-(phenylsulJonyl)-2-propenoI140e 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-nitrobenzaldehyde (1.66 g, II mmol ), phenyl 
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vinyl sulfone (1.8 g, II mmol) and DABCO (0.11 g, 1.0 mmol). Work-up and flash chromatography 
[on silica; elution with hexane-EtOAc (2:1)] gave, as pale yellow crystals, 1-(2-nitrophenyl}-2-
(phenylsul(onyl)-2-propenol I40e (1.1 g, 32 %), m.p. 85-88 'C (Found M+-NO, : 273.05699. 
C15HllNO,S requires M-NO" 273.05854); Vm,/ cm·' (nujol) 3476 (OH) and 1516 (NO,); DH (400 
MHz; CDCI3) 3.99 (lH, s, OH), 5.65 and 6.50 (2H, 2xs, C=CH, ), 6.05 (lH, s, CHOH), 7.47(lH, m, 
Ar-H), 7.54 (2H, m, Ar-H), 7.62 (2H, m, Ar-H), 7.82(2H, d, Ar-H) and 7.89 (2H, m, Ar-H); Dc (100 
MHz; CDC I}) 67.4 (CHOH), 124.6 (C=CH,) , 124.9 (C=CH,), 128.1 , 128.4, 129.2, 129.5 , 129.7, 
133.6, 133 .9 and 138.3 (Ar-C), 147.4 (C-NO,) and 151.0 (Ar-C); mlz 273 (M"-NO" 4.8 %) and 160 
(100). 
Phenyl 3-hydroxy-3-(2-nitrophenyl)propene-2-sulJonate IS0f 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate I40a was followed, using 2-nitrobenzaldehyde (2.1 g, 14 mmol) , phenyl 
vinyl- sulfonate (2.5 g, 14 mmo!) and DAB CO (0.11 g, I mmol). Work-up and flash 
chromatography [on silica gel ; elution with hexane-EtOAC (2: I )] gave, as a pale brown oil, phenyl 
3-hydroxy-3-(2-nitrophenyl)propene-2-sulJonate I40f (1.2 g, 27 %) (Found M+: 335.04546. 
C15H 13N06S requires M, 335.0 4636); vm,,/cm·' (nujol) 3476 (OH) and 1522 (NO,); DH (400 MHz; 
CDCI3) 3.82 (tH, br s, OH), 5.83 and 6.26 (2H, 2xs, C=CH,), 6.44 (lH, s, CHOH), 7.32 (lH, m, Ar-
H), 7.41 (2H, m, Ar-H) , 7.49 (2H, m, Ar-H), 7.55 (lH, t, Ar-H), 7.75 (lH, t, Ar-H), 7.91 (lH, d, Ar-
H) and 8.07(1H, d, Ar-H); Dc (400 MHz; CDCI3) 67.5 (CHOH), 122.1 (C=CH,), 127.3 (C=CH,), 
128.8, 129.5, 130.1, 131.9, 133.8,134.1,144.8,146.4, 147.9 and 149.3 (Ar-C); m/z 335 (M", 8 %) 
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and 94 (l00). 
3-Hydroxy-2-methylene-3-(2-nitrophenyl)propanaI150g v 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-nitrobenzaldehyde (5.0 g, 33 nunol), acrolein 
(1.9 g, 34 nunol ) and DAB CO (0.2 g, 2 mmol). Work-up and flash chromatography [on silica ; 
I 
elution with hexane-CHClil :3)] gave, as a brown oil, 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanal140g (0.42 g, 7.0 %) (Found M- NO,: 129.60351. C lOH9NO, requiresM-NO" 
129.6039); vm",!cm-I (nujol) 3463 (OH) and 1675 (C=O); OH (400 MHz; CDC1,) 3.63 (lH, brs, OH), 
4.86 and 5.76 (2 H, 2x s, C=CH,), 5.51 (lH, s, CHOH), 7.51 (lH, t, Ar-H), 7.78 (lH, t, Ar-H), 7.95 
(lH, d, Ar-H), 8.10 (lH, d, Ar-H) and 10.39 (lH, s, CHO); Oc (100 MHz; CDC1)) 62.9 (CHOH), 
122.4 (C=CH,), 124.1 (C=CH,), 128.6 (C-4'), 129.6 (C-5'), 134.0 (C-3') , 135.8 (C-2'), 140.5 (C-l'), 
143.2 (C-6') and 191.2 (CHO); m1z 129 (M'- NO" 6.4 %) and 65 (l00). 
I-Hydroxy-2-methylene-I-(2-nitrophenyl)pentan-3-one 150h 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-nitrobenzaldehyde (5.0 g, 33 mmol), ethyl vinyl 
ketone (2.8 g, 33 mmol) and DABCO (0.19 g, 1.7 nunol) . Work-up and flash chromatography [on 
silica; elution with hexane-EtOAc (2:1)] gave, as a pale brown oil, l -hydroxy-2-methylene-I-(2-
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nitrophenyl)pentan-3-one 140h (4.79 g, 62 %) (Found: M+ -NO,: 189.09051 . C12H 13N04 requires M-
N02,189.09155); Vrnox (nujol)/cm·1 3396 (OH) and 1675 (C= 0); OH (400 MHz; COCI,) 1.11 (3H, 
t, CH), 2.75 (2H, q, CH2), 3.73 (lH, br s, OH), 5.71 and 6.23 (2H, 2xs, C=CH2), 6.13 (lH, s, 
CHOH), 7.45 (lH, t, Ar-H), 7.64 (lH, t, Ar-H), 7.81 (lH, d, Ar-H) and 7.98 (lH, d, Ar-H); Oc (100 
MHz; COC1) 8.0 (CH), 30.9 (CH2), 67.6 (CHOH), 124.1 (C=CH2), 124.5 (C=CH2), 128.9 (C-3'), 
129.1 (C-6'), 133.6 (C-4'), 136,5 (C-5') , 148.0 (C-I') , 148.4 (C-2') and 202.6 (C=O); mlz 189 (M,9 
%) and 57 (100). 
Methyl 3-( 4,5-dimethoxy-2-nitrophenyl) -3-hydroxy -2-methylenepropanoate 140i -/ 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 4,5-dimethoxy-2-nitrobenzaldehyde (3 .0 g, 14 
mmol), methyl acrylate (1.2 g, 14.2 mmol) and OABCO (0.08 g, 0.7 mmol). Work-up and flash 
chromatography [on silica gel ; elution with hexane-CHCl) (1:3)] gave, as a brownish oil, methyl 3-
(4,5-dimethoxy-2-nitrophenyl)-3-hydroxy-2-methylenepropanoate 140i (0.58 g, 14 %) (Found M+: 
297.08578. C J3H1SN07 requires M, 297.08485); V rn" /cm·1 (nujol) 3489 (OH) and 1708 (C=O); OH 
(400MHz; COClJ 3.47 (lH, br s, OH), 3.76 (3H, s, OCH,). 3.94(3H, overlapping s, OCH,), 3.96 
(3H, overlapping s, OCH,), 5.55 and 6.27 (2H, 2xs, C=CH2), 6.29 (lH, overlapping S, CHOH), 7.24 
(IH, s, Ar-H) and 7.62 (lH, S, Ar-H); Oc (100 MHz; COC1) 52.3 (OCH), 56.7 (CHOH), 66.6 
(OCH,), 67.6 (OCH,), 107.6 (C=CH2), 1 10.0 (C=CH2) , 125.9(C-2'), 13 1.4 (C-3'), 139.9(C-l'), 141.4 
(C-6'), 147.8 (C-4'), 153.2 (C-5') and 166.6 (C=O) ; mlz 297 (M, 26 %) and 192 (100). 
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4-Hydroxy-4-(2-hydroxy-6-nitrophenyl)-3-methylenebutan-2-one 140j 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-nitrophenyl) 
propanoate 140a was followed, using 6-hydroxy-2-nitrobenzaldehyde (3.0 g, IS mmol), methyl vinyl 
ketone (1.3 g, IS mmol) and DAB CO (0.10 g, 0.90 mrnol). Work-up and flash chromatography [on 
silica; elution with hexane-EtOAc (I :2)) gave, as yellow crystals, 4-Hydroxy-4-(2-hydroxy-6-
nitropheny l)-3-methylenebutan-2-one 140j (0.95 g, 22 %), m.p. 133 - 136 °C (Found M'-NO,: 
191.07123. C Il H11NO, requires M-NO,, 191.07221); vm,, (nujol)/cm·1 3356 (OH) and 1675 (C=O); 
OH (400MHz; CDPD) 2 .35 (3H, s, CH3)' 4.S7 (JH, br s, OH), 5.65 and 6.36 (2H, 2xs, C=CH,), 6.17 
(lH, s, CHOH), 6.20 (lH, br s, ArOH), 6.SO (JH, dd, Ar-H) , 7.22 (JH, d, Ar-H) and S.OI (JH, d, Ar-
H); Oc (100 MHz; CDPD) 26.1 (CH3), 66.9 (CHOH), 115.4 (C=CH,), 116.0 (C=CH,), 126.1 (C-3') , 
129.0 (C-4'), 140.7 (C-I'), 143.2 (C-5'), 152.0 (C-6'), 164.1 (C-2') and 220.4 (C=O); m/z 191 (M'"-
NO"IOO%). 
Methyl 3-(2, 4-dinitrophenyl)-3-hydroxy-2-methylenepropanoate 140k 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2,4-dinitrobenzaldehyde (3.0 g, 15 mmol) , methyl 
acrylate (3 .0 g, 35 mrnol) and DABCO (0.09 g, 0.8 mmol) . Work-up and flash chromatography [on 
silica; elution with hexane-EtOAc-CHCI3 (1 :2: I)) gave, as pale green crystals, methyl 3-(2,4-
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dinitrophenyl)-3-hydroxy-2-methylenepropanoate 140k (1.5 g, 25 %), m.p 82 - 85°C (Found M+-
H20: 264.03844. C"H ION 20 7 requires M-HP, 264.038824); vm" fcm-' (nujol) 3436 (OH) and 1701 
(C=O); liH (400 MHz; CDCI]) 3.46 (IH, d, OH), 3.75 (3H, s, OCH]), 5.74 and 6.39 (2H, 2xs, 
C=CH2), 6.29 (lH, d, CHOH), 8.04 (lH, d, Ar-H), 8.45 (lH, d, Ar-H) and 8.78 (lH, s, Ar-H); lie 
(100 MHz; CDCI3) 52.8 (OCH]), 68.1 (CHOH), 117.7 (C-3') , 127.6 (C=CH2) , 127.7 (C=CH2) , 131.1 
(C-5'), 140.3 (C-6'), 143_1 (C-l'), 147.7 (C-2'), 148.6 (C-4') and 166.4 (C=O); m/z 264 (M-HP, 
40%) and 59 (100 ). 
Methyl 3-(5-chloro-2-nitrophenyl)-3-hydroxy-2-methylenepropanoate 1401 
The procedure described for the synthesis of methyl 3-hydroxy-2methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 5-chloro-2-nitrobenzaldehyde (3 .0 g, 16 mmol) , 
methyl acrylate (1.38 g, 16 mmol) and DAB CO (0.09 g, 1.0 mmol). Work-up and flash 
chromatography [on silica; elution with hexane-chloroform (I :3)] gave, as a brownish oil , methyl 
3-(5-chloro-2-nitrophenyl)-3-hydroxy-2-methylenepropanoate 1401 (2.25 g, 51 %) (Found M--CH;O: 
240.00666. C II HIOOsNCI requires M-CH;O, 240.00636); vm,,(nujol)fcm-' 3465 (OH) and 1714 
(C=O); liH (400MHz; CDC 1]) 3.38 (lH, d, OH), 3.75 (3H, s, OCH;), 5.58 and 6.35 (2H, 2xs, C=CH2), 
6.22 (lH, d, CHOH), 7.43 (lH, d, Ar-H), 7.76 (lH, s, Ar-H) and 7.94 (lH, d, Ar-H); lie (400 MHz; 
CDC13) 52.3 (OCH]), 67.5 (CHOH), 126.2 and 126.7 (C=CH2) , 128.8 (C-3'), 129.2 (C-6'), 138.3 (C-
2'),140.3 (C- l '),140.4 (C-4'), 145.1 (C-5') and 166.3 (C=O); mlz 240 (M -CH;O, 5 %) and 225 (l00) 
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4-Hydroxy-3 -methylene-4-{ 4, 5-(methylendioxy)-2-nitrophenyl] butan-2 -one 140m 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 4,5-(methylenedioxy)-2-nitrobenzaldehyde (3.0 
g, 15 mmol), methyl vinyl ketone (1.1 g, 13 mmol) and DABCO (0.09 , 0.8 mmol). Work-up and 
flash chromatography [on silica; elution with hexane-EtOAc (2:3) ] gave, as yellow crystals, 4-
hydroxy-3-melhylene-4-{4,5-(methylenedioxy)-2-nitrophenyl]butan-2-one 140m (1.4 g, 33 %), m.p. 
100 - 103°C (Found M+: 265.05794. C" H IIN06 requires M, 265.05864);lIm" (nujol)/ cm-' 3463 
(OH) and 1662 (C=O); 5H (400MHz; CDCI3) 2.37 (3H, s, CH3) , 3.44 (1 H, d, OH), 5.75 and 6.12 (2H, 
2xs, C=CH,), 6.19 (2H, s, OCH,O), 6.25 (lH, d, CHOH), 7.27 (I H, s, Ar-H) and 7.52 (I H, s, Ar-H) ; 
5c (100 MHz; CDCI3) 26.0 (CH3)' 67.6 (CHOH), 103 .7 (C=CH,), 105.7 (OCH,O), 107.8 (C=CH,), 
126.1 (C-2'), 134.1 (C-3'), 141.9 (C-1'), 1473 (C-4'), 149.1 (C-6'), 152.3 (C-5') and 200.0 (C=O); 
m/z 265 (M., 10 %) and 188 (100). 
I-Hydroxy-I-(3-methoxy-2-nitrophenyl)-2-methylenepenlan-3-one 1400 / 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 3-methoxy-2-nitrobenzaldehyde (2.0 g, 11 mmol), 
ethyl vinyl ketone (1.39 g, 16 mmol) and DABCO (0.062 g, 0.55 mmo1 ). Work-up and flash 
chromatography [on silica; elution with hexane-EtOAc-CHCI3 (1:1 :3)] gave, as a brownish oil, 1-
hydroxy-Ic(3-methoxy-2-nilrophenyl)-2-methylenepentan-3-one 1400 (2 .63 g, 89.7 %) (Found M+-
NO, : 219.10138. C13H 15NO, requires M-NO" 219.10212); " m" /cm-' (nujol) 3410 (OH) and 1668 
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(C=O); DH (400 MHz; CDC1,) 1.06 (3H, q, CH3CH" 2.71 (2H, t, CH3CH,), 3.49 (lH, d, OH), 3.87 
(3H, s, OCH,), 5.65 (lH, d, CHOH), 5.89 and 6.20 (2H, 2xs, C=CH,), 6.98 (lH, d, Ar-H) , 7.14 (lH, 
d, Ar-H) , 7.43 (IH, t, Ar-H); Dc (l00 MHz; CDCI3) 7.9 (CH1CH,), 31.0 (CH3CH,), 56.4 (CHOH), 
69.4 (OCH3), 112.0(C=CH,)and 119.4(C=CH,), 127.4 (C-5'), 131.1 (C-6') , 135.5 (C-4'), 140.1 (C-
3'), 146.9 (C-1'), 150.8 (C-2') and 202 .6 (C=O); mlz 219 (M-NO" 78%) and 57 (100). 
Attempted preparation of 1-(2, 6-dinitrophenyl)-I-hydroxy-2-methylenepentan-3-one 140p 
A solution of ethyl vinyl ketone (0.32 g, 38 mmol), 2,6-dinitrobenzaldehyde (0.5 g, 3 mmol) and 
DABCO (0.029 g, 0.26 g) in methanol (l0 ml) was stirred at room temperature for 20 days. The 
crude product was purified by flash chromatography [on silica; elution with EtOAc-hexane-CHCI3 
(3:1:1)] to afford only a trace quantity of what was indicated by 'H NMR analysis to be the desired 
product. 
1-(2-Chloro-6-nitrophenyl)-1-hydroxy-2 -methylenepentan-3 -one 1400 
The procedure described for the synthesis of methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140a was followed, using 2-chloro-6-nitrobenzaldehyde (0.5 g, 3 mmol), 
ethyl vinyl ketone (0.35 g, 4.1 mmol ) and DABCO (0.03 g, 0.3 mmol). Work-up and flash 
chromatography [on silica; elution with hexane-EtOAc-CDCI3 (I :2: I)] gave, as pale brown crystals, 
1-(2-chloro-6-nitrophenyl)-1-hydroxy-2-methylenepentan-3-one 1400 (0.27 g, 25 %), m.p. 77 - 79 
°C (Found M+ - NO,: 223.05111. C12H12NO,CI requires M-NO" 223.05258); vmox (nujol)/cm-' 3389 
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(OH) and 1664 (C=O); OH (400MHz; CDCI]) 1.07 (3H, t, CH]CH,), 2.73 (2H, m, CH]CH,), 3.54 (IH, 
d, OH), 5.89 and 6.29 (2H, 2xs, C=CH1), 6.22 (lH, d, CHOH), 7.36 (lH, t, Ar-H), 7.49 (I H, d, Ar-H) 
and 7.60 (lH, d, Ar-H); Oc (100 MHz; CDCI,) 8.0 (CH]CH,), 31.1 (CH,CH,), 68.8 (CHOH), 122.7 
(C=CH,), 126.7 (C=CH,), 129.2 (C-3'), 131.9 (C-2'), 133 .1 (C-4'), 135.5 (C-I'), 145.7 (C-5'), 151.4 
(C-6') and 202.4 (C=O); mlz 223 (M'-NO" 3 %) and 57 (100). 
3.2.2. Optimisation studies 
Following examination of various parameters the following conditions were found to be optimal. 
3.2.2.1. General procedure 
A solution of the 2-nitrobenzaldehyde derivative (I eq.) , the activated alkene (1.5 eq.) and DABCO 
(0.05 eq.) in chloroform (2 ml) was stirred at room temperature for 6 days to give the crude product 
which was purified by flash chromatography to afford the Baylis-Hillman product. Application of 
this procedure typically gave the expected products in significantly improved yields (60-95%; see 
Table 2, p. 48). 
3.2.2 Reductive CycIisation 
3.2.2.1. Catalytic Hydrogenation 
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3.2.2.1 .1. General Procedure 
A mixture of the Baylis-Hillman product (4.18 mmol) and 10 % palladium-on-carbon catalyst (0.15g) 
in ethanol (50ml) was stirred under hydrogen at atmospheric pressure for 90 min. The catalyst was 
filtered off and the solvent was evaporated from the filtrate in vacuo. The residue was dissolved in 
CH2CI2, and the solution was dried with anhydrous MgS04 and the solvent evaporated in vacuo to 
give the crude product, which was purified by flash chromatography. 
3-Methyl-2-quinolone 149a, 3-methyl-2-oxo-1 ,2,3,4-tetrahydroquinoline 150a and 4-hydroxy-3-
methyl-2-oxo-1 ,2,3, 4-tetrahydroquinoline 145a 
Following the general procedure, methyl 3 -hydroxy-2-methylene-3-(2-ni trophenyl)propanoate 140a 
was hydrogenated in the presence of palladium-on-carbon catalyst. The crude product was purified 
by flash chromatography [on silica; elution with hexane-EtOAc (3 :2)] to give three fractions . 
Fraction 1: 3-Methyl-2-quinolone 149a (O.IOg, 15 %), as a brownish oil, (Found M+: 159.18701. 
Calc. for CIOHPN: M, 159.18711); vmox fcm·' (nujol) 1649 (C=O); OH (400 MHz; CDC1,) 2.27 (3H, 
s, CH3), 7.18 (lH, d, Ar-H), 7.23 (lH, t, Ar-H), 7.42 (lH, m, Ar-H), 7.50 (lH, d, Ar-H), 7.62 (lH, 
s, 4-H) and 10.26 (lH, br s, NH); ocCI 00 MHz; CDC1,) 16.8 (CHJ), 115.6, 120.3, 122.4, 126.8, 129.3 
and 130.0 (Ar-C), 137.5 (C-5), 163.0 (Ar-C) and 164.5 (C=O). 
Fraction 2: 3-Methyl-2-oxo-l ,2,3,4-tetrahydroquinoline 150a, as a brown oil, (0.3Ig, 41 %) (Found 
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MH' : 162.091892. Calc for CIOH"NO: MH, 162.091889); Ym" /cm·1 (nujo1) 1664 (C=O); OH (400 
MHz; CDC1)) 1.27 (3H, d, CH)), 2.69 (IH, m, CH)CH), 2.97 (2H, dd, CH2), 6.71 (IH, d, Ar-H), 6.97 
(lH, t, Ar-H), 7.16 (lH, d, Ar-H), 7.55 (lH, br s, NH) and 7.59 (lH, t, Ar-H); ocC100 MHz; CDCl,) 
15.3 (CH)), 33.5 (CH2), 35.0 (CH3CH), 114.9 (C-5), 122.9 (C-6), 123.7 (C-4a), 127.5 (C-7), 128.1 
(C-8), 137.1 (C-8a) and 174.1 (C=O); mlz 162 (MH',100 %). 
Fraction 3: 4-Hydroxy-3-methyl-2-oxo- l ,2,3,4-tetrahydroquinoline 145a (0.12g, 18 %), as a brown 
oil, (Found MW: 178.086922. CIOH"N02 requires MH' , 178.086804); Vmox /cm·1 (nujol) 3423 (OH) 
and 1648 (C = 0); OH (400 MHz; CDC 1)) 1.67 (3H, d, CH,) , 2.79 (lH, m, CH3CH), 4.58 (lH, s, 
CHOH), 4.74 (1 H, d, OH), 6.97 (lH, d, Ar-H), 7.17 (I H, d, Ar-H), 7.19 (1 H, t, Ar-H), 7.28 (I H, t, 
Ar-H) and 10.47 (lH, br s, NH); oe (100 MHz; CDC I)) 10.4 (CH,), 41.4 (CH)CH), 70.8 (CHOH), 
115.4,123.5,128.0,129.7, 133.3 and 133.9 (Ar-C) and 167.5 (C=O); mlz 178 (MH' , 38 %) and 154 
(100 ). 
2,3-Dimethylquinoline 147c and 2,3-dimethylquinoline N-oxide 148c 
Following the general procedure, 4-hydroxy-3-methy1ene-4-(2-nitrophenyl)butanone 140c was 
hydrogenated in the presence of palladium-on-carbon catalyst. The crude product was purified by 
flash chromatography [on silica gel; elution with hexane-EtOAc (1:3 )] to give two fractions. 
Fraction I : 2,3-Dimethylquinoline 147c (0.14g, 20 %), as brownish crystals, m.p. 39-43 °C (Found: 
M+ 157.08929. Calc. for C11HlIN: M, 157.08915); Y mox /cm·1 (nujol) 1662 (N=C); OH (400MHz; 
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CDCI]) 2.44 (3H, s, CH), 2.68 (3H, s, CH), 7.45 (lH, m, Ar-H), 7.59(1H, m, Ar-H), 7.70 (IH, d, 
Ar-H), 7.82 (lH, s, Ar-H) and 7.99 (lH, d, Ar-H); Oc (100 MHz; CDCI3) 19.6 (CH3)' 23 .5 (CH), 
125.3 (C-4a), 125.5 (C-8a), 126.0 (C-6), 127.4 (C-7), 130.0 (C-5) , 134.9 (C-2), 135. 1 (C-3), 146.1 
(C-4) and 158.9 (C-8); m/z 157 (M', 100%). 
Fraction 2: 2,3-Dimethylquinoline N-oxide 148c (0.4g, 52 %), as yellowish crystals, m.p. 111-114 
°C (Found M' : 173.08338. Calc. for CllH, ,NO: M, 173 .08406); vm" / cm" (nujol) 1655 (N=C) and 
1317 (N-O); OH (400 MHz; CDCI) 2.47 (3H, s, CH), 2.70 (3H, s,CH) , 7.50 (lH, s, Ar-H), 7.56 
(IH, t, Ar-H), 7.65 (lH, t, Ar-H), 7.69 (lH, d, Ar-H) and 8.72 (lH, d, Ar-H); Oc (100 MHz; CDCI) 
14.8 (CH]), 20.3 (CH), 119.6 (C-6), 125.3 (C-2) , 125.5 (C-3), 127.3 (C-4a) , 127.9 (C-7), 129.2 (C-
8a), 130.9 (C-5), 139.9 (C-4) and 146.5 (C-8); m/z 173 (M' , 82 %) and 156 (100). 
2,3-Dimethyl-(6,7-methylenedioxy)quinoline 147m 
Following the general procedure, 4-hydroxy-2-methylene-4-[ 4,5-(methylenedioxy)-2-
nitrophenyl]butan-3-one 140m was hydrogenated in the presence of palladium-on-carbon catalyst. 
The crude product was purified by flash chromatography [on silica gel; elution with hexane-EtOAc 
(I :3)] to give, as yellowish crystals, 2,3-dimethyl-(6,7-methylenedioxy)quinoline 147m (0.22 g, 26 
%), m.p. 120-124 °C (Found M+: 201.07910. Calc. for C'2H ll N02: M, 201.07923); vmax /cm" (nujol) 
1238 (C=N); OH (400 MHz; CDCIJl2.37 (3H, s, CH3)' 2.59 (3H, s, CHJl, 6.04 (2H, s, OCHP), 6.94 
(lH, s, Ar-H), 7.28 (lH, s, Ar-H) and 7.64 (IH, s, Ar-H); Oc (100 MHz; CDCIJlI9.3 (CHJl, 23 .1 
(CH]), 101.4 (OCHP), 102.0 (C-6) , 105.0 (C-7), 123.9 (C-2), 126.5 (C-3), 134.7 (C-8), 144.2 (C-
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4a), 147.0 (C-5), 149.8 (C-8a) and 1563 (C-4); m/z 201 (M , 35 %) and 145 (100). 
2-Ethyl-3-methylquinoline 147b and 2-ethyl-3-methylquinoline N-oxide 148b 
Following the general procedure, l -hydroxy-2-methylene-5-(2-nitrophenyl)pentan-3-one 140h was 
hydrogenated in the presence of palladium-on-carbon catalyst. The crude product was purified by 
flash chromatography [on silica gel; elution with hexane-EtOAc (1:2 )] to give two fractions. 
Fraction 1: 2-Ethyl-3-methylquinoline N-oxide 148b (03 Ig, 39 %), as brown crystals, m.p. 66-69 
'C (Found M: 187.09970. CJ2H J3NO requires M, 187.09812); Ym" fern" (nujol) 1280 (N-O) and 
1611 (N=C); 6H (400 MHz; CDCI)) 130 (3H, t, CH)CH,), 2.49 (3H, s, CH)), 3 .18 (2H, q, CH,), 7.53 
(lH, s, Ar-H) , 7.55 (lH, t , Ar-H), 7.65 (IH, t, Ar-H), 7.90 (lH, d, Ar-H) and 8.92 (IH, d, Ar-H); 6c 
(100 MHz; CDCI)) 9.6 (CH3CH,), 19.5 (CHJ, 21.7 (CH,), 119.8 (C-4), 125.4 (C-5) , 127.1 (C-6), 
127.7 (C-7), 128.3 (C-3), 129.2 (C-8) , 130.5 (C-4a) , 141.1 (C-8a) and 151.2 (C-2); mlz 187 (M , 28 
%) and 170 (100). 
Fraction 2: 2-Ethyl-3-methylquinoline 147b (0.25g, 34 %), as a brownish oil, (Found M+: 171.1048. 
Calc. for CJ2HI3N: M, 171 .1052); Ym,x fern" (nujol) 1603 (N=C); 6H (400 MHz; CDCI)) 1.36 (3H, 
t, CH3CH,), 2.48 (3H, s, CH)), 3.00 (2H, q, CH,), 7.44 (IH, t, Ar-H) , 7.57 (lH, t, Ar-H), 7.67 (lH, 
d, Ar-H), 7.78 (lH, s, Ar-H) and 8.00 (lH, d, Ar-H); 6c (100 MHz; CDCI3) 12.8 (CH)CH,), 19.1 
(CH3) , 29.5 (CH,), 125.6 (C-6), 126.6 (C-7), 127.3 (C-2), 128.3 (C-5), 128.5 (C-4) , 129.4 (C-3), 
135.7 (C-8), 147.8 (C-4a) and 163.3 (C-8a); mlz 171 (M , 64 %) and 170 (100). 
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3-(PhenoxysulJonyl)quinoline N-oxide 148f 
Following the general procedure, phenyI3-hydroxy-3-(2-nitrophenyl)propene-2-sulfonate 140f( l.4g, 
4.2 mmol) was hydrogenated in the presence of palladium-on-carbon catalyst. The crude product was 
purified by flash chromatography [on silica gel ; elution with hexane-EtOAc (3: I)) to give, as an oil, 
3-(phenoxysulJonyl)quinoline N-oxide 148f(0.04 g, 4 %) (Found M+: 301 .0686. C! ,H 1!N03S requires 
M, 301.0771); vmox Icm·! (nujol) 1264 (N=C); 0H (400MHz; CDCIJ 7.08 (lH, d, Ar-H), 7.32 (2H, 
s, Ar-H), 7.78 (2H, t, Ar-H) , 7.94 (2H, t, Ar-H), 8.13 (lH, s, Ar-H), 8.26 (IH, s, 4-H), 8.77 (lH, t, 
Ar-H) and 8.86(lH, s, 2-H); Od lOO MHz, CDCIJ) 120.2 (C-2), 122.1 (C-6) , 125.9 (C-3), 127.8(C-
5), 128.3 (C-4a), 129.9 (Ar-C), 130.1 (Ar-C), 130.3 (C-8a), 130.6 (Ar-C), 132.5 (C-8), 133.6 (Ar-H), 
143.8 (C-4) and 149.2 (C-7); rn/z 301 (M,1 %) and 71(100). 
1-(2-Aminophenyl)-2 -phenylsulJonylpropanol161 e 
Following the general procedure, 1-(2-nitrophenyl)-2-(phenylsulfonyl)-2-propenol 140e was 
hydrogenated in the presence of palladium-on-carbon catalyst. The crude product was purified by 
flash chromatography [on silica gel ; elution with hexane-EtOAc (2: I )) to give, as yellow crystals, 
1-(2-aminophenyl)-2-(phenylsulJonyl)propanoI161e (0.39 g, 43 %), m.p. 63-66 °C (Found MW: 
292.10812. C!,H I7NSOJ requires MH" , 292.1 0840); vmox Icm·! (nujol) 3366 (OH) and 3162 (NH,); 
OH (400 MHz; CDCIJ ) 0.81/1.241 (3H, d, CHJ ) , 3.4114.09 (lH, m, SO,CH), 5.02 (lH, d,CHOH), 
1 Chemical shift data cited in this format, here and elsewhere, refer to signals corresponding to the 
diastereomeric components. 
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4.41 (2H, br s, NH,), 4.55 (lH, br s, OH), 6.62 (IH, m, Ar-H), 6.75 (lH, t, Ar-H), 6.85 (lH, d, Ar-
H), 7.07 (lH, m, Ar-H), 7.21 (lH, t, Ar-H), 7.60 (lH, m, Ar-H), 7.70 (lH, m, Ar-H), 7.82 (lH, t, Ar-
H) and 7.94 (lH, d, Ar-H); oc(lOO MHz; CDC13) 6.73 / 12.93 (CH3) ; 62.3 / 62.6 (CHCHJ, 
66.3/75.2 (CHOH), 116.3 / 117.1, 117.9 / 118.4, 122.6 / 124.0, 126.3 / 128.4, 128.8 / 129. 1 (Ar-C), 
129.3/ 129.7 and 133.9 / 137.0 (Ar-C), 142.2 (Ar-C), 144.3 (Ar-C) and 145.6 (C-NH,); mlz 292 
(Mfr , 34 %) and 122 (l00). 
3-(2-aminophenyl)-3-hydroxy-2-methylpropanenitrile 161d 
Following the general procedure, 3-hydroxy-2-methylene-3-(2-nitrophenyl)propanenitrile 140d 
(0.66g, 4 .2 mmol) was hydrogenated in the presence of paUadium-on-carbon catalyst. The crude 
product was purified by flash chromatography [on silica; elution with benzene-EtOAc (2: 1)] to give, 
as a brown oil, 3-(2-aminophenyl)-3-hydroxy-2-methylpropanenitrile 161d (0.43 g, 50 %) (Found 
Mfr: 177.102697. C]oH13N,O, requires MH , 177.102788); v max(nujol)/cm'!3371 (OH) and 2244 
(CN); OH (400 MHz; CDCI3) 1.08 / 1.35 (3H, d, CHJ, 3.24 / 3.39 (IH, m, CHCN), 3.93 (lH, br s, 
OH), 4.57 / 4.72 (lH, d, CHOH), 6.64 (lH, d, Ar-H), 6.70 (lH, m, Ar-H), 6.76 (lH, d, Ar-H), 7.11 
(lH, m, Ar-H) and 7.12 (2H, br s, NH,); Oc (l00 MHz; CDCI)) 14.2 / 15.3 (CH)), 30.26 130.9 
(CH3CH), 75.0 (CHOH), 117.7/117.5 (C-4'), 118.3/118.3 (C-5'), 121.2 1122.0 (C-l '), 122.7 /124.0 
(C-2'), 128.5/129.3 (C-6'), 129.6/129.8 (C-3') and 144.51145.0 (CN); mlz 177 (Mfr , 68 %) and 122 
(100). 
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6-Chloro-3-me thyl-2-quinolone 1491, 6-chloro-4-hydroxy-3-methyl-2 -oxo-1 . 2. 3. 4-
tetrahydroquinoline 1451 and 6-chloro-3-methyl-2-oxo-1. 2. 3. 4-tetrahydroquinoline 1501 
Following the general procedure , methyl 3-(5-chloro-2-nitrophenyl)-3-hydroxy-2-
methylenepropanoate 1401 was hydrogenated in the presence of the palladium-on-carbon catalyst. 
The crude product was purified by flash chromatography [on silica; elution with hexane-EtOAc (I :2)] 
to give three fractions. 
Fraction 1: 6-Chloro-3-methyl-2-quinolone 1491 (0.08g, 11 %), as brownish crystals , m.p. 200-204 
·C (Found M+: 193.02885. C,oHgNOCI requires M, 193 .02895); vmox fcm" (nujol) 1655 (C=O) and 
721 (C-CI); OH (400 MHz; CDCI,) 2.26 (3H, s, CH,), 7.21 (lH, m, Ar-H), 7.40 (IH, d, Ar-H), 7.49 
(lH, d, Ar-H), 7.61 (lH, s, Ar-H) and 9.96 (lH, br s, NH); Oc (l00 MHz; CDCI,) 16.8 (CH,), 115.7 
(C-5), 117.1 (C-3), 120.3 (C-7), 122.5 (C-8), 127.3 (C-6) , 129.4 (C-4), 137.4 (C-4a) , 137.6 (C-8a) 
and 174.8 (C-2) ; mlz 193 (M', 10 %) and 159 (100). 
Fraction 2: 6-Chloro-4-hydroxy-3-methyl-2-oxo-1. 2. 3. 4-tetrahydroqu inoline 1451 (O.07g, 9 %), as 
brown crystals, m.p. 105-109 °C (Found M+: 211.03657. C,oH,oN02CI requires M, 211.03952); vm., 
(nujol) f cm" 1662 (C=O) and 721 (C-CI); OH (400 MHz; CDCl,) 2.28 f 2.36 (3H, s, CH3) , 2.74 (1 H, 
m, CH,CH), 2.97 f 3.01 (lH, d, CHOH), 7.20 (lH, t, Ar-H), 7.28 (lH, t, Ar-H), 7.46 (lH, t, Ar-H), 
7.58 (lH, d, Ar-H), 8.34 (lH, br s, OH) and 11.67 (lH, br s, NH); oeC1 00 MHz, CDCI,) 16.7 (CH,), 
34.8 (CHOH), 112.9 (C-6), 115.9 (C-7), 122.5 (C-5), 126.8 (C-8), 129.7 (C-3), 134.4 (C-4a), 137.7 
(C-8a) and 175.0 (C=O); mlz 2 11 (M' , 18 %) and 159 (l00). 
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Fraction 3: 6-Chloro-3-methyl-2-oxo-1 ,2,3,4-tetrahydroquinoline 150\ (0.17g, 24 %), as yellowish 
crystals, m.p. 95-98 DC (Found M+: 195.03684. CiOHiONOCI requiresM, 195.03563); vmox (nujol) fcm· 
11662 (C=O); OH (400 MHz; CDC]3) 1.28 (3H, d, CH3), 2.69 (lH, m, CH3CH), 2.99 (2H, dd, CH,), 
6.71 (IH, d, Ar-H), 6.97 (JH, t, Ar-H), 7.14 (IH, d, Ar-H) and 7.50 (lH, br s, NH); OC (100 MHz; 
CDCI3) 15.3 (CH3)' 33.4 (C-4), 35 .1 (C-3), 115.2 (C-4a), 122.9 (C-7), 123.4 (C-8a) , 127.4 (C-5), 
127.9 (C-8), 137.1 (C-6) and 175.0 (C-2); mlz 195 (M', 4 %) and 161 (100). 
3.2.2.2 . Reduction with Tin Chloride56 
3.2.2.2.1. General Procedure 
To a solution of the substrate in absolute EtOH (10 ml) was added SnCI, .2H,O (5 eq.). The mixture 
was stirred at 70°C under nitrogen for 5 hours and then, after cooling, poured on to ice. The 
resulting mixture was made slightly basic (PH 7 - 8) by the addition of saturated aq. NaHC03, and 
then extracted repeatedly with EtOAc. The combined organic phases were thoroughly washed with 
saturated brine and dried over anhydrous Na,S04. The solvent was evaporated in vacuo to afford the 
crude product. 
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Methyll,2-dihydroquinoline-3-carboxylate 162a 
The general procedure was followed, using methyl 3-hydroxy-2-methylene-3-(2-nitrophenyl)-
propanoate 140a (1.19 g, 5 mmol) and SnCl,.2Hp (5.64 g, 25 mmol) in MeOH (10 ml). t The crude 
product was purified by flash chromatography [on silica; elution with hexane-EtOAc (I :3)] to afford 
,as an off-white powder, methyI1,2-dihydroquinoline-3-carboxylate 162a (0.47 g, 50 %), m.p. 175-
177 °C (Found M: 189.07852. C"H"NO, requires M, 189.07898); Vm" (nujol) fcm" 1642 (C=O); 
OH (400 MHz; CDCI3) 3.55 (3H, s, CH,), 4.56 (2H, s, CH,), 7.2 1 (lH, m, Ar-H), 7.45 (l H, m, Ar-H), 
7.47 (lH, m, Ar-H), 7.55 (lH, d, Ar-H), 7.87 (IH, s, Ar-H) and 12.27 (lH, br s, NH); Oc (lOOMHz; 
CDCI3) 59.0 (CH3)' 69.3 (C-2), 115.8 (C-5), 120.0 (C-3) , 122.6 (C-6), 127.6 (C-7) , 129.9 (C-8), 
130.0 (C-4a), 136.3 (C-3) , 137.6 (C-8a) and 163.2 (C=O); mlz 189 (M' , 18 %) and 159 (100). 
Ethyl 1,2- dihydroquinoline-3-carboxylate 162b 
Method 1: 
The general procedure was followed , USlllg ethyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 140b (1.26 g, 5 mmol) and SnCI, .2H,O (5 .64 g, 25 mmol). The crude 
product was purified by flash chromatography [on silica; elution with hexane-EtOAc (I :3)] to 
t Use of ethanol as solvent resulted in transesterification to afford the ethyl ester 162b (see method 
2 below). 
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afford, as whitish powder, ethyl 1,2- dihyhroquinoline-3-carboxylate 162b (0.15 g, 15 %), m.p. 
170-172°C (Found M+: 203.09556. C1ZHIlNOz requires M, 203.09463); vmox (nujol)/cm·1 1662 
(C=O); 0H (400 MHz; CDC I)) 1.26 (3H, t, CH)), 3.69 (2H, q, CHZCHJ), 4.56 (2H, s, CHz), 7.22(lH, 
t, Ar-H), 7.44 (lH, t, Ar-H) , 7.59 (lH, d, Ar-H), 7.95 (lH, s, Ar-H) and 9.95 (lH, br s, NH); oe 
(lOOMHz; CDCI3) 15.3 (CHJ) , 66.7 (OCHz), 67.2 (C-2), 115.3 (C-5), 120.1 (C-3), 122.7 (C-6), 127.8 
(C-7), 129.9 (C-8), 130.7 (C-4a), 136.0(C-4), 137.3 (C-8a) and 162.5 (C=O); m1z 204 (M', I %) 
and 159 (100). 
Method 2: 
When methyl 4-hyclroxy-3-methylene-4-(2-nitrophenyl)butan-2-one 150a was reacted with 
SnClz.2Hp using ethanol as solvent, the transesterified product, ethyl 1,2-dihydroquinoline-3-
carboxylate 162b (0.12g, 13 %) was obtained. 
3-Acetyl-1-hydroxy-1,2-dihydroquinoline 163c 
The general procedure was followed, using 4-hydroxy-3-methylene-4-(2-nitrophenyl)butan-2-one 
140c (0.44 g, 2 mmol) and SnClz.2Hp (2.25 g, 10 mmol) in MeOH (4 ml). The crude product was 
purified by flash chromatography [on silica gel; elution with hexane-EtOAc (2 :3)] to afford, as a 
yellow powder, 3-acetyl-1-hydroxy-l ,2-dihydroquinoline 163c (0.07 g, 21 %), m.p. 77-80 °C (Found 
MH+: 191.086798. C11H1p zN requires MH·, 191.086804); vmox (nujol) fcm· 1 1622 (C=O); OH 
(400MHz; CDC]3) 2.45 (3H, s, CHJ, 5.01 (2H, s, CHz), 6.81 (IH, d, Ar-H), 7.13 (lH, t, Ar-H), 7.29 
(lH, m, Ar-H), 7.33 (lH, s, OH), 7.38 (IH, s, OH), 7.43 (lH, d, Ar-H) and 7.48 (lH, s, 4-H); oe 
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(lOOMHz; CDCI,) 25.8 (CH,), 77.2 (C-2), 116.5 (C-5), 124.3 (C-6), 125.6 (C-3), 130.0 (C-7), 134.4 
(C-8), 138.3 (C-4), 142.5 (C-4a), 150.3 (C-8a) and 198.5 (C=O); mlz 190 (M, 87 %) and 189 (100). 
I-Hydroxy-3-propanoyl-l, 2 -dihydroquinoline 163h 
The general procedure was followed, using l-hydroxy-2-methylene-l-(2-nitrophenyl)pentan-3-one 
140h (0.47 g, 2 mmol) and SnCI,.2H,O (2.26 g,1 0 mmol) in MeOH (4 ml). The crude product was 
purified by flash chromatography [on silica; elution with hexane-EtOAc-CHCIJ (I :2: I») to afford, 
as yellow crystals, I-hydroxy-3-propanoyl-l,2-dihydroquinoline 163h (0.04 g, 10 %), m.p. 85-89 °C 
(Found MH+: 204.102416. C"HJJNO, requires MH' , 204.102454); vmox (nujol)/cm" 1628 (C=O); 
OH (400MHz; CDC I,) 1.16 (3H, t, CH,), 2.84 (2H, q, CH3CH,), 4.98 (2H, s, CH,), 6.81 (lH, d, Ar-H), 
7.11 (lH, t, Ar-H), 7.27 7(lH, t, Ar-H), 7.34 (IH, s, OH), 7.42 (lH, d, Ar-H) and 7.49 (lH, s, 4-H); 
oc( IOO MHz; CDCI,) 8.5 (CH,), 30.6 (CH3CH,), 77.1 (C-2), 116.5 (C-5), 124.3 (C-6) , 125.3 (C-3), 
129.8 (C-7), 134.3 (C-8), 136.8 (C-4 ), 142.0 (C-4a), 150.2 (C-8a) and 201.1 (C=O); mlz 204 (MH', 
83 %) and 203 (100). 
I -Hydroxy-8-methoxy-3-propanoyl-l, 2-dihydroquinoline 1620 
The general procedure was followed, usmg l-hydroxy-2-methylene-I-(3 -methoxy-2-
nitrophenyl)pentan-3-one 1400 (l.33g, 5.01 mmol) and SnCI.(5 .64g, 24.9 mmol). The crude product 
was purified by flash chromatography [on silica; elution with hexane-EtOAc (I :2)) to afford, as 
yellow crystals, l-hydroxy-8-methoxy-3-propanoyl-I,2-dihydroquinoline 1620 (0.70 g, 64 %), m.p. 
5558 °C (Found MH+: 218.118132. CJJH"NO, requires MH', 218.118104); Vm" (nujol)/ cm-' 3160 
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(NH) and 1691 (C=O); OH (400 MHz; CDC I)) 1.34 (3H, t, CH)), 3.03 (2H, q, CH,CH,), 4.02 (3H, s, 
OCH)), 4. 90 (2H, s, CH,), 6.70 (lH, d, Ar-H) , 7.32 (lH, t, Ar-H) , 7.35 (IH, S, OH), 7.38 (1 H, d, Ar-
H) and 7.99 (lH, s, 4-H); Oc (100 MHz, CDC1J 13 .7 (CH,), 28 .8 (CH,QI,), 55.1 (OCH)),62.0 
(CH2)' 107.6 (C-5), 118.9 (C-6), 125.9 (C-7), 128.10 (C-4a), 132.7 (C-8a), 134.0 (C-4), 138.9 (C-3), 
154.8(C-8) and 160.9 (C=O); mlz 218 (MH' ,lOO%). 
Attempted reduction of methyl 3-(2,4-dinitrophenyl)-3-hydroxy-2-methylenepropanoate 140k with 
stannous chloride 
To a solution of methyl 3-(2,4-dinitrophenyl)-3-hydroxy-2-methylenepropanoate 140k (0.94g,) in 
absolute EtOH was added SnCl, .2H,o (3.8g, l6.8mmol). The mixture was to stirred at 70 °C under 
nitrogen for 5 hours and the solution was allowed to cool and then poured on to ice. The resulting 
mixture was made slightly basic by adding aqueous sodium carbonate. Extraction afforded none of 
the expected product. 
3.2.3. Interconversion of quinoline and quinoline-N-oxide derivatives 
3.2.3.1. Oxidation of2,3-dimethylquinoline 147c with MCPBAs7 
To a stirred solution of2,3-dimethylquinoline 147c (0.1 g, 0.6 mmol) in CHC1) (0.6 ml) was added 
MCPBA (O.llg, 0.64 mmol), portionwise, during 3 min. at room temperature. The mixture was 
stirred for 24 hours, and then any excess MCPBA destroyed (as indicated by wet starch-iodide paper) 
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by the addition of solid Na,S,O, . Dissolved m-chlorobenzoic acid was precipitated from the solution 
as the potassium salt by the addition of solid K,C03 with stirring. The solids were removed by 
filtration, and the solvent was removed from the filtrate in vacuo to give a yellow solid. 'H NMR 
analysis revealed the presence of some unreacted starting material, and further MCPBA (0.1 g) was 
added and the mixture stirred for another 24 hours. After work-up, 2,3-dimethylquinoline N-oxide 
148c was obtained as a yellow powder (0.09 g, 78 %). 
3.2.3 .2. Deoxygenation of2,3-dimethylquinoline N-oxide 148c 
2,3-Dimethylquinoline N-oxide 148c (0.08 g,0.46 mmol) and DMF (8 ml) were stirred together at 
room temperature. PBr3 (0.2 ml, 0.7 mmol) was added and stirring continued for I hour. The 
mixture was poured into saturated aqueous NaHC03 and the resulting mixture extracted with EtOAc 
(3x 20 ml). The extracts were combined, washed with saturated aqueous NaHCO) and brine, dried 
(anhyd. MgSO,) and filtered. The solvent was removed in vacuo to give 2,3 -dimethylquinoline 
147c(0.06g, 77 %). 
3.2.3.3. Selective in situ oxygenation and deoxygenation reactions 
A: Formation o/the mixture o/2,3-dimethylquinoline 147c and its N-oxide 148c 
A mixture of3-hydroxy-2-methylene-3-(2-nitrophenyl)butan-2-on e 140c (0 .5g, 2.26 mmol) and 10% 
palladium-on-carbon catalyst( 40 mg) dissolved in methanol (40 ml) was subjected to hydrogenation 
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(see general method, p 81) for 3 hours. The catalyst was filtered off and the solvent evaporated from 
the filtrate in vacuo . The residue was dissolved in CH2Cl2, dried (anhydrous MgS04), and the solvent 
evaporated in vacuo to afford, as a brown oil , a mixture of 2,3-dimethylquinoline 147c and 2,3-
dimethylquinoline N-oxide 148c (0.409g). 
B: Formation of 2,3-dimethylquinoline N-oxide 148cfrom the mixture 
To a stirred solution of the foregoing mixture (0.135g) of 2,3-dimethylquinoline 147c and 2,3-
dimethylquinoline N-oxide 148c in CHC13 (0.5 ml) was added MCPBA (0.107 g), portionwise, over 
15 minutes at room temperature. The mixture was stirred for 24 hours, before any excess MCPBA 
(wet starch-iodide paper) was destroyed by the addition of solid Na2S20 S' Dissolved m-chlorobenzoic 
acid was precipitated from solution as the potassium salt by the addition of solid K2C03 with stirring. 
The solids were removed by filtration and the filtrate dried (MgS04) ; the solvent was removed in 
vacuo to give, as yellow crystals, 2,3-dimethylquinoline N-oxide 148c (0.116g, 85 %) 
c: Formation of 2,3-dimethylquinoline 147 ji-om the mixture 
A mixture (0.125g) of2,3-dimethylquinoline 147c and 2,3-dimethylquinolineN-oxide 148c in DMF 
(3 ml) was stirred at room temperature. PBr3 (0.2 ml, 0.7 mmol) was added and stirring continued 
for 1 hour. The mixture was poured into saturated aqueous NaHC03, and the resulting mixture 
extracted with EtOAc (3x20 ml). The extracts were combined, washed with saturated aqueous 
NaHC03, and brine, dried (anhyd. MgS04) and filtered. The solvent was removed from the filtrate 
96 
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in vacuo to give, as yellow crystals, 2,3-dimethylquinoline 147c (0.1 07g, 86%). 
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